Incorporation of a Mo in a Rubredoxin-Type Centre of a de Novo Designed α3-DIV-L21C Three Helix Bundle Peptide by Bragança, Pedro Miguel da Silva
  
 
 
 
 
 
 
 
 
 
 
 
 
 
PEDRO MIGUEL DA SILVA BRAGANÇA 
 
 
[Nome completo do autor] 
 
 
[Nome completo do autor] 
 
 
[Nome completo do autor] 
 
 
 
[Nome completo do autor] 
 
 
[Nome completo do autor] 
 
 
[Nome completo do autor] 
 
 
[Nome completo do autor] 
 
 
Graduate degree in Biochemistry 
 
 
[Habilitações Académicas] 
 
 
[Habilitações Académicas] 
 
 
[Habilitações Académicas] 
 
 
 
[Habilitações Académicas] 
 
 
[Habilitações Académicas] 
 
 
[Habilitações Académicas] 
 
 
[Habilitações Académicas] 
 
 
October, 2019 
 
 
Incorporation of Mo in a Rubredoxin-Type Centre of a de 
Novo Designed α3-DIV-L21C Three Helix Bundle Peptide 
 
 
[Título da Tese] 
 
Dissertation to obtain a Master Degree in Biochemistry 
 
 
Dissertação para obtenção do Grau de Mestre em 
[Engenharia Informática] 
 
Supervisor: Doutora Marta S. P. Carepo, Investigadora, Faculdade de 
Ciências e Tecnologias da Universidade Nova de Lisboa 
  
Co-supervisor: Professor Doutor José J. G. Moura, Professor Catedrático 
Aposentado, Faculdade de Ciências e Tecnologias da 
Universidade Nova de Lisboa 
  
 
 Júri: 
Presidente: Professora Maria Alice Santos Pereira 
Arguente: Professor José Ricardo Ramos Franco Tavares 
 ii 
 
  
 
R 
In
c
o
rp
o
ra
ti
o
n
 o
f 
M
o
 i
n
 a
 R
u
b
re
d
o
x
in
-T
y
p
e
 C
e
n
tr
e
 o
f 
a
 d
e
 N
o
v
o
 D
e
s
ig
n
e
d
 α
3
-D
IV
-L
2
1
C
 T
h
re
e
 H
e
lix
 B
u
n
d
le
 P
e
p
ti
d
e
 
P
e
d
ro
 M
ig
u
e
l 
d
a
 S
ilv
a
 B
ra
g
a
n
ç
a
 
 iii 
 
 
 
  
PEDRO MIGUEL DA SILVA BRAGANÇA 
 
 
[Nome completo do autor] 
 
 
[Nome completo do autor] 
 
 
[Nome completo do autor] 
 
 
 
[Nome completo do autor] 
 
 
[Nome completo do autor] 
 
 
[Nome completo do autor] 
 
 
[Nome completo do autor] 
 
 
Graduate degree in Biochemistry 
 
 
[Habilitações Académicas] 
 
 
[Habilitações Académicas] 
 
 
[Habilitações Académicas] 
 
 
[Habilitações Académicas] 
 
[Habilitações Académicas] 
 
[Habilitações Académicas] 
 
[Habilitações Académicas] 
 
Incorporation of Mo in a Rubredoxin-Type Centre of a de 
Novo Designed α3-DIV-L21C Three Helix Bundle Peptide 
 
 
[Título da Tese] 
 
Dissertation to obtain a Master Degree in Biochemistry 
 
 
Dissertação para obtenção do Grau de Mestre em 
[Engenharia Informática] 
 
Sup rvisor: Doutora Marta S. P. Carepo, Investigadora, Faculdade de 
Ciências e Tecnologias da Universidade Nova de Lisboa 
  
Co-supervisor: Professor Doutor José J. G. Moura, Professor Catedrático 
Aposentado, Faculdade de Ciências e Tecnologias da 
Universidade Nova de Lisboa 
  
 
 
October, 2019 
 
 
Júri: 
Presidente: Professora Maria Alice Santos Pereira 
Arguente: Professor José Ricardo Ramos Franco Tavares 
 iv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Incorporation of a Mo in a Rubredoxin-Type Centre of a de Novo Designed 
α3-DIV-L21C Three Helix Bundle Peptide 
Copyright © Pedro Miguel da Silva Bragança, Faculdade de Ciências e Tecnolo-
gia, Universidade Nova de Lisboa. 
A Faculdade de Ciências e Tecnologia e a Universidade Nova de Lisboa têm o 
direito, perpétuo e sem limites geográficos, de arquivar e publicar esta disserta-
ção através de exemplares impressos reproduzidos em papel ou de forma digital, 
ou por qualquer outro meio conhecido ou que venha a ser inventado, e de a 
divulgar através de repositórios científicos e de admitir a sua cópia e distribuição 
com objetivos educacionais ou de investigação, não comerciais, desde que seja 
dado crédito ao autor e editor.
 v 
 
 
1 Acknowledgments 
Um afetuoso agradecimento à Doutora Marta S. P. Carepo por todo o apoio, pela boa-disposição diária, 
pelos excelentes conselhos e por expandir os meus conhecimentos nas mais diversas áreas. 
Um profundo agradecimento ao Professor Doutor José J. G. Moura e Professora Doutora Isabel Moura 
por me receberem tão amavelmente no seu grupo de investigação e por ampliarem o meu interesse no 
ramo da química bioinorgânica. 
Um agradecimento à Doutora Cristina M. Cordas por aprofundar os meus conhecimentos na área da 
eletroquímica e pela sua perseverança mesmo quando o misterioso ruído de final de tarde visitava. 
Um agradecimento à Doutora Sofia Pauleta, ao Doutor Alejandro Samhan-Arias, à Doutora Luísa Maia e à 
Doutora Maria João Nunes pela carinhosa receção no grupo e permanente boa-disposição. 
Um agradecimento a todos os restantes colegas de grupo pela partilha de ideias e pelos momentos de 
descontração. 
Un ringraziamento a Maddalena Elia per l'ottimo lavoro svolto in precedenza nel gruppo. 
Quero agradecer à minha família por todo o apoio ao longo destes 5 anos e por me proporcionar esta 
oportunidade para expandir os minhas capacidades. 
Quero agradecer a todos os meus amigos (VdB) pelo suporte e companheirismo ao longo destes anos. 
Alguns foram mais difíceis, outros menos e outros mais ou menos. 
Um agradecimento especial à Asiyah Esmail pelo amor, pelo carinho, pelo suporte e pelo apoio desde que 
nos conhecemos. Obrigado por me aturares quando não estou nos meus dias (são quase todos).  
Um agradecimento à Faculdade de Ciência e Tecnologia da Universidade Nova de Lisboa. 
Um agradecimento à FCT/MCTES pelo financiamento (UID/QUI/50006/2019). 
 
 
 
 vi 
 
 
 
 
 
 vii 
 
2 Abstract 
 
Approximately one-third of all proteins and enzymes require one or more metal atoms to 
perform their catalytic functions. Presently, the rational design and engineer of small, simple and 
stable peptides scaffolds to mimic catalytic metal-centres of complex proteins is an important goal 
in the area of protein design and search for centres with environmental, biotechnological and 
basic research impact. In this work, a de novo designed α3DIV-L21C peptide that possesses a 
rubredoxin-type centre as the metal-binding site was used to incorporate a Mo atom to mimic, 
specifically, the tetrathiolate environment found in the active-site of molybdenum-bis pyranopterin 
guanosine dinucleotide-containing enzyme (Mo-bis PGD). The Mo-α3DIV-L21C peptide 
reconstitution was acceded by ICP-AES to optimize the reconstitution conditions tested and a 1:1 
peptide/metal ratio was obtained using a 1:10 peptide/metal ratio for reconstitution. Using UV-vis 
spectroscopy, the emergence of two broad bands, with a maximum absorption between 310-330 
nm (ε320nm = 7400 M-1.cm-1) and 460-475 nm (ε470nm = 2000 M-1.cm-1), confirm the metal 
incorporation within the tetracysteinyl environment. Circular dichroism (CD) studies, in the visible 
region, further confirmed the metal incorporation through the appearance of a positive band with 
a maximum at 394 nm. Furthermore, secondary structure profile and tertiary structure fingerprint 
were examined, under TCEP-induced reducing and non-reducing conditions, as well as thermal 
stability studies in both far-UV and visible regions. Differential Scanning Calorimetry (DSC) was 
used to perform a thermal denaturation analysis and define thermodynamic parameters for Mo-
α3DIVL21C peptide. Thermogram fitted well to a reversible monomeric two-state model, with a 
Tm value of 66 ºC, a ΔHcal value of 846.4 kJ.mol-1 and a ΔHvH value of 920.03 kJ.mol-1. Preliminary 
electrochemical results through the use of cyclic voltammetry (in a thin-layer regime) suggest an 
initial oxidation state of Mo(VI), within the metal-binding site, and formal potential (E0’) of -406 mV 
vs. NHE with a capability to undergo one-electron transfer process (Mo(VI)/Mo(V)). Moreover, 
reducing tests attained with different reducing agents and followed by spectroscopy seems in 
agreement with this assumption. 
 
Keywords: a de novo protein design, molybdenum, DMSOR family, rubredoxin 
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3 Resumo 
 
Aproximadamente um terço de todas as proteínas e enzimas requerem um ou mais átomos 
metálicos para efetuarem as suas funções catalíticas. Atualmente, o design racional e construção 
de esqueletos peptídicos pequenos, simples e estáveis para mimetizarem centros-metálicos ca-
talíticos de proteínas complexas é uma meta importante na área de design de proteínas e na 
descoberta de centros com importância ambiental, biotecnológica e académica. Neste trabalho, 
o péptido a de novo designed α3DIV-L21C que possuí um centro do tipo rubredoxina, como local 
de coordenação de metais, foi usado para incorporar um átomo de Mo para mimetizar, especifi-
camente, o ambiente tetratiolado encontrado no centro-ativo das enzimas que contêm o cofator 
molibdénio-bis piranopterino (Mo-bis PGD). A confirmação da reconstituição do péptido Mo-
α3DIV-L21C foi efetuada por ICP-AES e o 1:1 rácio de péptido/metal foi obtido, utilizando um 
rácio de 1:10 de péptido/metal para a reconstituição. Utilizando espectroscopia de UV-vis, a 
emersão de duas bandas largas, com um máximo de absorção entre 310-330 nm (ε320nm = 7400 
M-1.cm-1) e 460-475 nm (ε470nm = 2000 M-1.cm-1), confirma a incorporação do metal no ambiente 
tetracisteinílico. Estudos de dicroísmo circular (CD), na região do visível, confirmam a incorpora-
ção do metal através do aparecimento de uma banda positiva com um máximo a 394 nm. Adici-
onalmente, o perfil da estrutura secundária e o “impressão digital” da estrutura terciária foram 
examinados, sob condições redutoras induzidas por TCEP e não redutoras, bem como estudos 
de estabilidade térmica em ambas as regiões do far-UV e do visível. Foi utilizada calorimetria de 
varrimento diferencial (DSC) para efetuar uma análise de desnaturação térmica e definir parâ-
metros termodinâmicos para o péptido Mo-α3DIVL21C. Os termogramas ajustaram devidamente 
a um modelo monomérico reversível de dois-estados, com um valor de Tm de 66 ºC, um valor de 
ΔHcal de 846.4 kJ.mol-1 e um valor de ΔHvH de 920.03 kJ.mol-1. Estudo eletroquímicos preliminares 
através de voltametria cíclica (em regime de camada fina) sugerem um estado de oxidação inicial 
de Mo(VI), no sítio de coordenação metálico, e um potencial formal (E0’) de -406 mV vs. NHE 
com a possibilidade da transferência de um eletrão Mo(VI)/Mo(V). Adicionalmente, testes de re-
dução realizados com diferentes agentes redutores e seguidos por espetroscopia parecem estar 
de acordo com esta suposição. 
Palavras-chave: a de novo design de proteínas, molibdénio, família DMSOR, rubredoxina
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Preamble 
The 2019 Periodic Table of the Chemical Elements contains 118 elements organized and 
related by their intrinsic physical-chemical properties to their neighbours (rows and columns). Of 
these 118 elements, slightly more than 30 are believed to have a biological role in all forms of life 
on Earth (Fig.1), from eukaryotic organisms to prokaryotic organisms, but only 12 of these 30 
elements occur in all known kingdoms of life 1,2. Of all the elements currently used in biological 
systems, transition metals may have been the fundamental elements that boosted the evolution 
of life and differentiation to superior organisms 3,4. The introduction of metals in proteins and 
enzymes, in addition to the geological role in the ecosystems, connect the environment and life, 
creating an unbreakable link between inorganic and biologic chemistry 5–7. This relationship was 
so strictly necessary that it has been estimated that one-half to one-third of the functions and 
structural features require the presence of a metal ion 8. The metal active-sites allows the protein 
to perform several of the most complex and essential reactions in nature and can be divided into 
four basic functional types, (I) structural, (II) storage, (III) electron transfer processes and (IV) 
catalytic 9. The cooperation between functional complexity with regulatory roles, such as sensors 
and on regulatory processes, placed some metalloenzymes as mediators of essential biological 
processes, such as cellular respiration, photosynthesis and nitrogen fixation. Due to these 
abilities, the reproducibility and mimicking of their functions are one of the main goals in 
bioinorganic chemistry. In the present work, our attention will be oriented to the only biological-
active metal from the second transition row, the molybdenum atom. 
 
Figure 0.1. Chemical elements used by living organisms in biological processes. Edited from 1. 
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1 Chapter 1. Introduction 
1. Rational Protein Design: Artificial enzymes 
Over the past 30 years, the field of protein design has been increasing significantly in the areas 
of fundamental research (biochemistry and biotechnology), of clinical applications and applied 
(industrial) areas such as in energy production and production of added value products 10,11. This 
field comprehends several techniques in which new or existing proteins are enhanced or novel 
biological functions are created (artificial enzymes 12–14), and an important spin-off is the 
understanding of protein structure-function relationship 15. Nature, with the help of evolution and 
millions of years of trial and error, has been in the vanguard of this field, creating new structural 
detailed scaffolds with high efficiency and selectivity. 
Protein engineering has a multitude of applications and can resolve current underlying 
problems, such as the structure and folding prediction to achieve desired protein functions. Such 
systems are an important tool to understand the fundamental rules that govern the structure-
function relationship in proteins. Nevertheless, the creation of unusual structures with novel 
specificities and proprieties appear to encounter a prevailing problem in current structure 
prediction studies, the “protein folding problem” 16. The protein folding is a complex process that 
involves the transformation of the information encoded by the primary sequence of a protein in a 
functional and stable tertiary structure. To master this folding process, additional intrinsic 
thermodynamic and kinetic information are required.  
The thermodynamic and kinetic parameters play important roles in the creation of a stable 
protein scaffold. These parameters have to balance the unfavourable entropy created by the 
folding process and the favourable enthalpy of the system. Furthermore, the fundamental 
interactions, such as hydrophobic, electrostatic, Van der Waals and hydrogen bond interactions 
also determine the stability of the protein structure. Each interaction has particular proprieties that 
are exploited in order to build a stable protein construct, like the building of salt bridges by 
1 
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electrostatic interactions, generation of hydrogen bonds to create secondary structures and the 
use of hydrophobic interactions as a driving force for folding processes.   
Additionally, the incorporation of a metal-binding complicates the strategies of protein design. 
In some reported cases, the metal ion is responsible for the folding process and it is the major 
force to overcome the unfavourable entropy. Nonetheless, other requirements such as ligand 
recognition, metal specificity and, ultimately, substrate specificity, impacts this folding process. 
Even though creating functional designed metalloprotein systems is a difficult process, 
considering the biological essential roles that some of the native metalloenzymes have in Nature, 
this is one of the most attractive areas in the field of protein design. 17,18 
Metalloproteins design aims to create efficient catalysts that perform biological functions with 
the same selectivity and high efficiency under mild conditions. Besides, the construction of novel 
metal-binding sites in designed or native scaffolds can unravel the structural and catalytic roles 
imposed by the metal ions 19. Moreover, intrinsic chemical proprieties of metals, such as magnetic 
proprieties imposed by different redox states, makes the metal active-sites the perfect target for 
protein design, since each metal-ligand interaction and each metal redox state have specific 
spectroscopic features that can be followed by classical spectroscopic techniques 20.  
Furthermore, the biological functions of metalloenzymes can be divided into three types: 
structural, catalytic and electron transfer processes 9. Each one of these types has been 
extensively reviewed over the years. 21–23 
Rational protein (metalloprotein) design of artificial enzymes can be addressed with two 
approaches: the protein redesign, by the use of native proteins templates, and a de novo protein 
design, by the creation of peptide templates from scratch 24. We can consider these two 
approaches by which we can understand how a certain structure, at which is related a specific 
function, can influence the performance of a protein. The classical top-down approach exploits 
any kind of perturbation (e.g. site direct mutagenesis) in an existing scaffold to determine their 
contribution to the protein’s functions, but the bottom-up approach or rational protein design 24 
uses specific structural features and proprieties that are integrated or to an existing system 
(redesign) or a construct built up from “scratch” (a de novo design). Both of these latter methods 
are important from a coordination and biochemistry point-of-view and for the mimicking of crucial 
metalloenzymes 24. In the next sections, we will explore in-depth these two approaches.  
 
1.1. Protein Redesign: “native” proteins templates 
Data from a structural classification method reveals that only 1,200 different scaffolds are used 
as structural domains in more than 38,000 protein crystal structures deposited in Protein Data 
Bank (PDB). This data suggests that Nature, with a limited number of scaffolds, have achieved 
highly functional protein variability 25. Subsequently, over years of evolution, each protein active-
site was tuned to be unique, selective and specific to a certain biological function. 18 
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Protein redesign applies this same concept used by Nature, through the design and engineer 
of new metal-binding sites into existing native proteins, instead of creating novel scaffolds. This 
strategy aims to improve or generate novel properties in well-known proteins (e.g. in rubredoxins) 
to achieve new activities, modify stereoselectivities or improve substrate specificity. Such 
modifications help us clarify the structure-function relationship in native proteins and allow us to 
construct new proteins for biomedical and pharmaceutical applications.  
Specifically, the redesign of metalloenzymes coincides with the redesign of the metal active-
site inside a native protein scaffold. Such natural scaffolds make the engineering of metal-binding 
sites more achievable since they are more stable and more resistant to chemical modifications. 
Moreover, native proteins normally can catalyse more than one chemical transformation in their 
single active-site, which allows a wider range of chemical transformations to occur within existing 
scaffolds. In addition, the efficiency of the catalytic activity in some metalloenzymes is not optimal, 
which leaves some chemical freedom to achieve improved activities and/or specificities. 24   
Metalloprotein redesign strategy seems to be the most effective approach since native 
metalloproteins already have a specific metal-binding site and can adapt easily to environmental 
changes. The redesign also allows incorporation of only those features that are thought to 
influence the reactivity and can shed light on the most relevant residues that affect the reaction 
catalysed by the enzyme. Furthermore, by applying a minimal number of modifications, the 
fundamental requirements for a certain function can be studied without the stabilities and 
symmetries problems associated with a de novo design of scaffolds. 22 
Usually, such new functional features can be attained by playing with the metal ions chemistry. 
Such modifications can be achieved by changing exclusively the metal ion in the metal-binding 
site or by altering the type and/or the number of ligand coordination arrangements (amino acid 
mutations). Nevertheless, in the present work, we will focus solely on the metal-substitution 
approach, which exploits the metal-switching affinity, or metal-binding promiscuity, of some 
proteins for the construction of artificial metalloenzymes. 26 
The metal-substitution approach exploits the catalytic promiscuity of some enzymes 27. This 
modifications in the metal binding specificity can lead to the creation of an artificial metalloenzyme 
with novel proprieties. To perform this strategy two experimental steps are crucial: the extraction 
of the “native” metal to obtain an apo-protein form, and the reconstitution of this apo-form with the 
incorporation of the desired new metal 28. The incorporation of distinct metal atoms within the 
same metal-binding site offers the opportunity to compare different metal active-sites within the 
same protein scaffold. 20 
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1.1.1. Rubredoxins: “native” protein template for Protein Redesign 
One outstanding model metalloprotein used for protein redesign is Rubredoxin (Rd). This 
simple iron-sulphur bacterial protein (≈6 kDa) participates in electron transfer processes in 
biological systems and contains a single Fe ion coordinated by four cysteinate sulphurs {Fe(S-
Cys)4}, arranged in a distorted tetrahedral environment. The distinct mononuclear tetrahedral 
tetrathiolate metal-binding site can cycle between the high spin Fe(II) and high spin Fe(III) 
oxidation states. 29 
Structurally, Rd exhibits a specific “rubredoxin-like” fold that represents a superfamily by 
themselves. Its polypeptide chain is composed of two or three helical turns and a comparatively 
short three-stranded antiparallel β-sheet. The Fe ion is connected by two cysteines provided by 
the N-terminal, whereas the last two cysteines are in a hydrogen-bonded turn in the C-terminus. 
Is the protein-specific consensus sequence that recognizes the metal ion and causes the folding 
of the protein in a particular conformation, originating a –CX2C–Xn–CX2C– motif. 30 
Rubredoxins exhibited reduction potentials close to 0 Volts, with a spread of ≈ 100 mV for both 
negative and positive sides. This discrepancy is influenced by hydrogen bonding interactions 
between cysteine sulphurs and vicinal amide protons 31,32. Due to this particular chemistry, Rd 
drives a great interest in metal substitutions since provides a cysteinyl potential coordination 
environment, similar to others sulphur-rich environments such as zinc enzymes 33,34, bacterial 
[NiFe] hydrogenase 35,36, Cu-chaperones 37,38, cupredoxins 39,40 and molybdenum-containing 
proteins 41.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common Coordination Sites: 
 Zinc fingers – Zn 
 Bacterial Hydrogenases – Ni 
 Cupredoxins – Cu 
 Molybdoenzymes – Mo 
 EPR and Mössbauer – 57Fe, Co 
 X-ray – Co, Ni, Zn, Ga, Cd, Hg, Ge 
 NMR – Zn, Cd, Co, Ni, Ga, Ge 
Bio-models 
Zn 
Spectroscopic 
probes 
Hg 
Native Rubredoxin 
Ni 
Cu 
Mo 
57Fe 
Co 
C
Ga 
In 
Zn 
Ge 
Figure 1.1. Protein redesign using metal-substituted derivatives of rubredoxin. 
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The Rd derivatives are an important tool to elucidate structural and functional aspects of metal 
sites involving coordination spheres rich in sulphur atoms. The metal-substituted Rds can be used 
as structural probes to elucidate the structure-function relationship and as bio-models to model 
complex active-sites of native enzymes. The tetracysteinyl metal coordination site of Rds has the 
ability to incorporate a wide variety of metal ions, and until now several metal-substituted Rds 
containing 57Fe(II) 42, Co(II) 43, Ni(II) 44,45, Cu(I) 46,47, Zn(II) 48,49, Cd(II) 43, Hg(II) 43, Ga(III) 43, In(III) 
50, Ge(IV) 51 and Mo(VI, V, IV) 52 have been prepared and characterized. (Fig.1.1) 
 
 
1.1.1.1. Mo-substituted Rd: a model for Mo-containing proteins 
Mo-substituted rubredoxin (Mo-Rd) from the species Desulfovibrio gigas (D. gigas) has been 
successfully obtained, through a dialysis process in acidic conditions 52. The aim was to mimic 
the mononuclear molybdenum-bis pyranopterin centre encountered in the DMSOR family, by 
coordination of the Mo atom with the four cysteinate sulphurs and by exogenous ligands, such as 
oxygen and sulphur atom, forming a Mo(VI)-(S-Cys)4(=O)(X) complex (X = –OH or –SR).  
UV-vis spectral characterization confirms the incorporation of the molybdenum atom in the 
tetracysteinyl metal-binding site of rubredoxin. Besides a maximum absorption band at 278 nm (ε 
= 17.77 mM−1.cm−1), the two unresolved shoulders at 314 and 450 nm (ε = 8.01 and 1.02 
mM−1.cm−1, respectively) can be assigned to molybdenum-thiolate charge-transfer bands. 
Raman spectroscopy further revealed Mo-S bending and stretching vibrational modes, and 
suggest that the Mo-centre entails in a Mo=O(=O…H–protein) or Mo=O(–OH) type of coordination 
sphere, similar to the one observed in the oxidized form of arsenite oxidase 53.  
EPR studies show that the Mo-centre stabilizes the metal atom in a +6 oxidation state and can 
be reduced to Mo(IV) via Mo(V) by a reducing agent, like sodium dithionite (E0’ = -660 mV vs. 
NHE). Additional spectroscopic studies show that dithiothreitol (DTT) cannot reduce the 
molybdenum atom (E0’ = -330 mV vs. NHE), but can coordinate with the metal-centre as an 
exogenous thiol ligand. 52 
 
 
 
 
 
 
 
 
 
 
AsIIIO3
3- AsVO4
3- 
b) a) 
Figure 1.2. Comparison of the metal-binding site coordination geometry in (a) native rubredoxin and 
(b) molybdenum-substituted Rd. Edited from 52. 
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Furthermore, activity studies suggest the ability to catalyse oxo transfer reactions similar to 
the native mononuclear molybdenum-containing enzymes. Such reaction involves oxidation of 
arsenite (AsIIIO3
3-) to arsenate (AsVO4
3-), like as seen in the native arsenite oxidase 52. This study 
demonstrates that the incorporation of a molybdenum atom into an Rd scaffold can reproduce a 
system with the same coordination sphere chemistry, spectroscopic features and catalytical 
functions that in native Mo-containing enzymes. Is safe to conclude that this redesign Rd is a 
structural and functional analogue to the Mo-bis PGD family (DMSOR family). (Fig.1.2) 
 
1.1.1.2. Molybdenum in Biology 
When we outlook the elements that are essential for life on Earth, molybdenum is hardly ever 
considered. Nevertheless, its biological history is almost as old as life on Earth.  
Molybdenum is a transition metal from the 6th group and the second transition series of the 
Periodic Table of Elements. Its electronic configuration, [Kr] 4d5 5s1, provide rich and versatile 
redox chemistry with several valence states, from +II to +VI. Nonetheless, under physiological 
conditions, the oxidation states just vary between +IV a +VI, with exception of nitrogenase 
enzyme that holds a +III oxidation state. With this oxidation states versatility, Mo-containing 
enzymes can catalyse either one-electron, Mo(VI) ↔ Mo(V); Mo(V) ↔ Mo(IV), or two-electron, 
Mo(VI) ↔ Mo(IV), oxidation-reduction reactions. 54 
Although it is an essential trace metal that is present in all domains of life, from archaea, 
bacteria and eukarya 55,56, is biological demand is low when compared with other essential 
biological trace metals, such as Fe and Cu 57. Despite this, Mo continues to be the building block 
of several cofactors used by more than 60 enzymes present in the nitrogen, carbon and sulphur 
biogeochemical cycles 58,59. As a result of the versatility of Mo first coordination sphere, the 
formation of oxides and sulphides highly enhance the Mo involvement in biological processes. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Schematic representation of Mo uptake and storage in prokaryotes (dashed lines) 
and in eukaryotes (solid lines). The red dots are the oxidized form and the green dots are the 
reduced form of molybdenum. Retrieved from 57. 
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Furthermore, the specific “atom exchanger” ability, in particular on “oxygen atom transfer“, 
present in molybdenum complexes is balanced by the tendency of Mo to bind oxo groups and its 
capacity to simply lose a single oxygen atom. Due to this adaptable chemistry, many enzymes 
took advantage and start to catalyse several different atom-transfer reactions, like oxygen, proton 
and sulphur atom insertion and abstraction redox reactions, or even non-redox hydration 
reactions. 60,61  
Since the molybdenum atom has such rich chemistry, its intracellular concentration has to be 
highly regulated by uptake systems, to protect it from the cell’s oxidising environment and avoid 
unwanted atom-transfer and electron-transfer reactions 62. Such regulation is made by the 
synthesis of specific cofactors that are carried by transport proteins to be inserted in apo-
enzymes, generating a mature and functional metalloenzyme (Fig.1.3). The Mo intracellular 
transport in prokaryotes is performed by a high-affinity molybdate transporter from the ABC family 
(ModA, ModB and ModC) 63. In contrast, the molybdate uptake systems in eukaryotes are still 
being discovered 64. In anoxic conditions, due to the extremely low oxygen concentration, the 
intracellular molybdate anion (MoO42-), in sulphate-reducing bacteria, is converted to 
tetrathiomolybdate (MoS42-) by oxygen-sulphur exchange.65 
 
1.1.1.3. Molybdenum-containing Proteins 
Molybdoproteins are proteins that harbour a molybdenum atom in their active-site. This class 
contains, until now, more than 60 enzymes that can perform a panoply of reactions, extending 
from the oxygen-, proton- and sulphur-transfer redox reactions, to non-redox hydration reactions. 
The Mo active-site can perform one or two-electron oxidation and reduction reactions, so the 
molybdenum atom can cycle between Mo(VI), Mo(V) and Mo(IV) oxidation states. The ability to 
change the oxidation state allows this class of metalloproteins to catalyse several metabolic 
reactions in the carbon, nitrogen and sulphur biogeochemical cycles. 66,67 
The Mo-containing proteins can be distinguished in two types depending on the interaction 
between the cofactor and the metal ion. The first typology is found when the Mo atom is in the 
enzyme’s active-site as a mononuclear form, coordinated by one or two pyranopterin cofactor 
molecules, and the second is found in unique heteronuclear cofactors present in the Nitrogenase 
enzyme 68,69, the orange protein (ORP) 70,71 and the molybdenum response protein (MorP) 72. In 
the first typology, the Mo-dependent enzymes can be classified into three large families: xanthine 
oxidase (XO), sulphite oxidase (SO) and dimethylsulfoxide reductase (DMSOR) families, 
depending on the number of pyranopterin cofactors and type of additional ligands (oxygen, 
sulphur and selenium) are coordinated with the Mo centre 41,73. (Fig.1.4) 
In these three mononuclear families, one Mo atom is coordinated with one or two pyranopterin 
cofactor molecules, through the cis-dithiolene (–S–C=C–S–) group, to create molybdopterin 
(MPT) moiety. Additionally, to increase the variability, addition of a second nucleotide after Moco 
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formation (Mo-MPT), such as cytosine or guanine, to the Mo-MPT structure led to the 
development of MCD (molybdopterin cytosine dinucleotide) and MGD (molybdopterin guanosine 
dinucleotide) variants. 74 (Fig.1.5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The pterin cofactor not only affects the structural arrangement of the metal, by enabling a 
correct position of Mo in the active-site but also controls the redox activity of the metal centre. 
Several studies have suggested that the catalytic ability is shaped by “environment” of the metal 
first and second coordination spheres, and so on by the pterin cofactor. This cofactor acts like a 
“wire” that conduct the electrons to and from the molybdenum atom, consequently facilitating the 
intramolecular electron transfer processes. Furthermore, to tune the metal oxidation state, each 
enzyme holds a binding pocket that controls the pyranopterin cofactor conformation and 
selectively controls the pterin structural isoforms. 75–77 
 
 
 
 
 
 
 
 
Methylphosphate 
moiety 
Pterin 
moiety 
Pyrano 
moiety 
Dithiolene moiety M 
Figure 1.5. Moieties in the molybdopyranopterin cofactor. Edited from 41. 
Figure 1.4. Active-site structure of the enzymatic molybdenum-containing proteins and the non-enzymatic pro-
teins. Only the cis-dithiolene group of the pyranopterin cofactor, in the XO, SO and DMSOR families, is repre-
sented. Edited from 41. 
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Moreover, the metal reactivity is also influenced by the other atoms (O, S and Se) in the metal 
coordination sphere. The modulation of the reduction potential of the Mo centre is a consequence 
of changing the energy levels of the metal ground state dxy orbital 78–80. The ligand-coordination 
geometry is imposed by the polypeptide chain to produce an entatic state able to stabilize and 
facilitate the oxo- and sulphur-groups association and/or dissociation. This influence is observed 
when we compared a Mo atom coordinated with two pyranopterin cofactors (Mo-containing 
enzyme) to a synthetic model compound. The first displays a trigonal prismatic coordination 
geometry and the latter an octahedral geometry. 81,82 
In this work, we are mainly interested in the tetrathiolate environment in the DMSOR family 
since the Mo atom is coordinated by two pyranopterin guanosine dinucleotide (also named Mo-
bis PGD enzymes) (Fig.1.6). This family have more structural and functional variability among the 
three large families. The active-site holds a molybdenum atom coordinated with four sulphurs in 
a trigonal prismatic geometry ([Mo(VI)O(MPT)2(X)], with additional ligands (Y and X groups), such 
as terminal oxygen, sulphur and selenium atoms, and/or the O and S atoms from Asp, Ser, Cys 
and SeCys residues. 41,83 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The high biological-variability of the DMSOR family probably derives from the replacing of the 
oxygens with sulphur atoms that, ultimately, increase the reduction potential. Additionally, the 
electron transfer rate (ET) and the metal-dithiolene fold-angle also increases. The interaction 
between the metal in-plane and the sulphur-π orbitals are stabilized by large fold-angles and this 
effect is important in the regeneration of the Mo active-site during catalysis and for electron 
transfer processes.84,85 
 
 
 
Figure 1.6. Complete structure of the active-site of the DMSOR or Mo-bis 
pyranopterin guanosine dinucleotide (PGD) family. Retrieved from 67. 
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1.1.1.4. Mo-heteronuclear non-enzymatic centres  
Heteronuclear centres in Mo-containing proteins are unusual. These centres are characterised 
by the coordination of a molybdenum atom with one or more different metals in the active-site, 
bridge by sulphur atoms. The two heteronuclear centres recognized in the non-enzymatic Mo-
containing proteins are the [S2MoS2CuS2MoS2] cluster in the Orange protein 70,71 and the most 
recently discovered molybdenum response associated protein (MorP), in Desulfovibrio 
alaskensis, that contains a novel [MoS2-[Fe2-S2]-S2-Mo] heterometallic cluster 72. 
The biosynthesis of these heteronuclear clusters is a challenge because of the different 
coordination geometries that the molybdenum atom can acquire and the lack of 
tetrathiomolybdate complexes (MoS42-) that are aqueous-soluble and stable. Although such 
synthesis is challenging, several Mo-containing heteronuclear clusters were successfully 
synthesized, using the tetrathiomolybdate (TTM) compound, by protein-assisted syntheses, like 
the heterometallic cluster in the Orange Protein (ORP) 86. 
The Orange Protein is a small monomeric protein of ≈12 kDa, of currently unknown physiological 
function, isolated from sulphate-reducing bacteria (SRB). The ORP harbours a unique 
molybdenum-cooper heterometallic centre in a linear mixed-metal sulphide cluster – 
[S2MoS2CuS2MoS2]. This cluster is non-covalently bound to the protein scaffold, but it is stabilized 
by hydrophobic and electrostatic interactions. 86,87 
In the literature is reported the Mo-Cu cluster reconstitution, for both D. gigas apo-ORP and D. 
alaskensis G20 apo-ORPs, by protein metal cluster-assisted synthesis using the 
tetrathiomolybdate compound as the synthetic precursor. The formation of the Mo-Cu cluster was 
achieved by reacting this extremely redox-active synthetic compound (TTM) with copper chloride 
in the presence of the apo-protein. TTM and copper chloride are able to react in the absence of 
protein generating several polynuclear clusters in which one Mo atom is bound to several Cu ions. 
In the presence of apo-ORP and with 2Mo:1Cu metal stoichiometry it is possible to synthesize a 
Mo-Cu cluster similar to the one discovered in the ORP. 86,87 
Furthermore, the protein-assisted synthesis of novel heterometallic derivatives in which the 
molybdenum-sulphur cluster is coordinated in an S2MoS2−M−S2MoS2 system (M = Fe, Co, Ni or 
Cd), is also described in the literature. These syntheses were promoted by the Orange Protein 
using the TTM compound as a synthetic precursor. 88 
The relevance for synthesizing these sulphur-coordinated transition-metal complexes emerge 
due to their rich redox chemistry that is exhaustively explored by nature and in the industry. Such 
successful syntheses only were achieved due to the use of tetrathiomolybdate compound as a 
precursor. It is clear that the TTM compound is a remarkable “building block” for the synthesis of 
biological-important polynuclear complexes and a molybdenum atom-providing compound for 
protein redesign and a de novo protein design. 
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1.1.1.5. Tetrathiomolybdate: a model synthetic compound 
Thiometallate anions, MOxS4-xn-, are well-known compounds recognised by their strong 
colours that arise from low energy S  M charge transfer transitions. Usually, the transition metal 
(M) is in a high oxidation state which offers an unusual redox property and can be used as a 
ligand to synthesize several heterometal complexes. 89 
We will focus only in the thiometallate anions of the molybdenum (VI), MoOxS4-xn-, more 
specifically in the tetrathiomolybdate (TTM) compound – MoS42-, since among all thiomolybdates 
compounds, this has been used as a Mo-containing synthetic compound. Furthermore, TTM is 
one of the studied thiomolybdate compounds due to their ease preparation, thermal and hydrolytic 
stability and biological roles. 
Tetrathiomolybdate synthesis consists of sequential substitutions of the oxygen atoms from a 
molybdate anion – MoO42- 90. The latter form is colourless, however by substituting the oxygens 
by sulphur atoms, charge transitions from S  Mo give rise to the characteristic intense colours 
of the thiometallate anions, such yellow in MoO3S2-, orange in MoO2S22-, orange-red in MoOS32-, 
and strong-red in MoS42- form. Each one of these forms has specific charge transitions in the UV-
visible region and, therefore, whole absorb and interact with light at particular wavelengths 89. 
(Fig.1.7) (Table.1.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thiomolybdates  UV/Vis λ/nm  (ε dm
3
.mol
-1
.cm
-1
) 
MoO
3
S
2-
 288 (–), 390 (–) 
MoO
2
S
2
2-
 288 (0.39), 320 (0.64), 394 (0.29) 
MoOS
3
2-
 315 (0.84), 398 (0.81), 465 (0.14) 
MoS
4
2- 316 (1.76), 465 (1.24) 
Figure 1.7. UV-Visible spectra of molybdate and thiomolybdates: 
(a) MoO42-, (b) MoO3S2-, (c) MoO2S22- , (d) MoOS32- and (e) MoS42-. 
Retrieved from 92. 
Table 1.1. UV-visible characteristic bands and Molar Extinction 
Coefficients for each thiomolybdate anions. Retrieved from 89. 
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Additionally, the ability to form linear and complex clusters by bridging sulphide ions between 
different metals are and have been widely studied, such as Cu- and Fe-heterometal complexes 
91,92. The synthesis of these inorganic complexes normally converges in the mimicking of active-
sites of some metalloproteins, like for instances the Mo-Cu active-site of the Orange Protein. 
Furthermore, TTM-heterometal compounds have also been used in clinical applications, such a 
chelating-agent for Cu atoms in the treatment of Wilson’s disease (a genetic disorder that leads 
to Cu accumulation in the body) 93, or even in kidney cancer-related treatments by the use of TTM 
in association with antiangiogenic therapies 94.  
 
 
1.2. A De Novo Protein Design  
Over the last decade, the field of a de novo protein design expanded in a panoply of 
applications and these advances have been extensively reviewed over the years 80–85. 
Challenging as protein redesign strategies, a de novo or “from scratch” design offers us the 
possibility to disentangle fundamental structure-function relationships while exploiting novel 
proprieties and functions in peptides and proteins, without the existence of necessary relation to 
native protein sequences 100. Contrarily to protein redesign, a de novo design postulates that the 
primary amino acid sequence determines the protein’s three-dimensional structure.  
In order to design such scaffolds, the construction of stable native-like frameworks by exploring 
fundamental interactions that contribute to the folding and topology of protein constructs, such as 
hydrophobic, hydrogen bonding, salt-bridges and Van der Waals contacts, are crucial to avoid 
the restrains produced by protein’s domains and motifs, allostery or multiple metal-binding sites 
22,101. Although this concept is based on minimal design, the intent is to keep a minimum of 
structural and functional complexity to accomplish protein-like catalytic activities. 102,103 
Early developments in this field begin with the assembled of stable and common secondary 
structures using hydrophobic interactions as a driving force for folding, and salt-bridges and Van 
der Walls contacts to guide the topology of the construct. Recently, rather than designing new 
scaffolds from scratch, previous constructs can be used to design, for instances, metalloproteins, 
once the existing ones cover the most common structural motifs found in nature. 104,105 
A de novo metalloprotein design is a novel area that has begun to emerge in this field. This 
area aims to incorporate a metal cofactor-binding site into stable a de novo scaffolds without 
affecting its stability, to mimic native protein active-sites and, ultimately, their catalytic functions. 
Several successful examples have been reported, in which similar structural and functional 
characteristics of their native analogues have been acquired, and even new functions have been 
achieved by non-biological metal complexes with high selectivity. 24 
Such multidisciplinary field has many advantages, like the functionalization of synthetic 
peptide’s active-site in order to accomplish natural and unnatural reactions found in biological 
systems and the creation of novel sable scaffolds with enzyme-like selectivity’s.  
 13 
 
 
1.2.1. Four-helix bundle scaffolds: α2D family 
The lack of long-range interactions and the time-consuming synthesis of peptides and proteins 
scaffolds are one of the major drawbacks of rational a de novo design. Due to this, it is usual that 
the synthesis of simple and stable complexes, such as four-helix bundle scaffolds, were the 
starting-point to adapt and define the fold of other a de novo α-helix bundles proteins and 
peptides. 101 (Table.1.2) 
 
 
 
 
 
 
 
 
The helix-loop-helix dimer α2D is a model example in which single amphiphilic helices 
aggregate spontaneously. Such folding process is a consequence of the binding energies of 
hydrophobic interactions that are enough to drive the thermodynamic equilibrium to an energetic-
favourable folded state 106–110. This α2D dimer is the result of several specific amino acid 
modifications in primordial helix-bundle α2-scaffolds, like the α2B and the α2C scaffolds that initially 
adopted a molten globule-like state 111. (Fig.1.8) 
 
 
 
 
 
 
 
 
 
 
 
 
 
α2 family Primary Sequence 
α2B Ac-GELEELLKKLKELLK-GPTTG-ELEELLKKLKELLKG-NH2 
α2C Ac-GEVEELLKKFKELWK-GPTTG-EIEELFKKFKELIKG-NH2 
α2D Ac-GEVEELEKKFKELWK-GPTTG-EIEELHKKFHELIKG-NH2 
Ile33 
Ile22 
His30 
His26 
Phe29 
Phe10 
Val3 
Trp14 
Glu7 
Figure 1.8. Structure of the α2D scaffold (PDB entry: 1QP6) 108. 
The aminoacid modifications are highlighted as in the Table 2. 
The image was visualized in Chimera1.11. 
Table 1.2. α2 peptides family sequences 
99. Modifications in the primary sequences 
are highlighted at blue and green letters. 
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1.2.2. Three-helix bundle scaffolds: α3D family 
The basic principles that govern the four-helix bundle scaffolds design are also valid for the 
construction of three-helix bundle scaffolds, such as the α3D native-like peptide 101,112 (Fig.1.9). 
The single polypeptide chain preassembles in an antiparallel three-helix bundle in a clockwise or 
counter-clockwise configuration. Both topologies have been already successfully designed, the 
counter-clockwise conformation was constructed by DeGrado group 113 and the clockwise 
configuration was design by Johansson et al 114. However, favourable interhelical interactions 
only occur in the DeGrado design peptide, which is a typical outcome of a negative design.  
 
 
 
 
 
 
 
 
 
The α3D scaffold was constructed using a hierarchic approach, in which hydrophobic, 
electrostatic and helix-capping interactions were enhanced in order to promote a stable packed 
core 17. Thereafter, Tebo and Pecoraro reported a metalloenzyme-design study where they 
replace three apolar residues by three histidine’s residues to create a metal-binding site (α3DH3). 
They successfully incorporate two different first-row transition metals in the tris(histidine) motif, 
Zn(II) and Cu(I/II), and obtained two different catalytic activities, the hydration of CO2 (ZnII) and 
reduction of nitrite (CuI/II). 115,116 
Such results highlight the potential of a de novo metalloenzymes design. Although these 
catalytic activities are far from enzyme-like efficiencies, this study demonstrates how the 
evolutionary pressure sculptured the surrounding protein environment in order to tune their 
biological functions. 
 
 
 
 
 
Leu18 
Leu28 
Leu67 
Figure 1.9. Structure of the α3D scaffold (PDB: 2A3D) 112. The 
image was visualised in Chimera1.11. 
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1.2.3. α3D Framework Functionalization: tris(cysteine) environment 
The functionalization of the α3D scaffold by the incorporation of a tris(cysteine) was also 
achieved by Pecoraro group. The construction of this variant aimed to create a thiol-rich 
coordination environment found in native metalloregulatory proteins, such as in the MerR, 
ArsR/SmtB and CadC/CmtR proteins.117 
The incorporation of a tris(cysteine) symmetric metal-binding site in the α3D system promoted 
the binding of several metals, like Co(II), Zn(II), Cd(II),Hg(II) and As(III), resulting in the develop 
of a novel α-helical bundle metalloprotein – α3DIV – that can sequester toxic heavy metals 118,119. 
Furthermore, the amino acid substitution (3Leu  3Cys) increased the α-helical content of the 
α3D scaffold and promoted additional stabilizing packing interactions, resulting in a more 
compacted core. 112 (Fig.1.10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Both variants, α3D and α3DIV, present the same counterclockwise topology, but in the α3DIV 
scaffold the sequestering of the transition metals Cd(II), Hg(II), and Pb(II) induced further stability 
and do not introduce any relevant conformational changes 120. Therefore, this novel synthetic 
peptide presents a stable framework for forthcoming design metallopeptides that could perform 
new catalytic reactions, in the same manner that was exploited in this work. 
 
1.2.4. α3D Framework Functionalization: tetra(cysteine) environment 
Iron-sulphur proteins are among the earliest biological metalloredox centres and include a 
broad range of mononuclear and mixed-clusters structures. The simplest and one of the most 
carefully studied iron-sulphur protein is the electron-transfer 1-centre rubredoxin – Fe(Cys)4. 
Rubredoxin is an ideal target for clarifying structure-function relationships in metalloproteins, once 
Cys67 
Cys18 
Cys28 
Figure 1.10. Structure of the α3DIV scaffold (PDB: 2MTQ) 117. 
The image was visualised in Chimera1.11. 
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its single-iron active-site only relies on the protein-derived thiolates for assembly and not on 
external inorganic sulphides.  
In fact, there are several studies reported in the literature that exploit the design of the 
rubredoxin-like active-sites and its specific rubredoxin-like fold 121–123. Nevertheless, the Rd 
electron transfer nature difficult its reproducibility, since the designed scaffold has to coordinate 
and stabilise both Fe(II) and Fe(III) oxidation states.  
The first reported example of a de novo design scaffold with a rubredoxin-like active-site in a 
novel and unrelated native fold is the synthetic peptide α3DIV-L21C 124 (Fig.1.11). This construct 
was obtained through functionalization of the three-helix bundle scaffold α3DIV, with the creation 
of a tetrathiolate metal-binding site by amino acid substitution of a Leu residue by a Cys. Their 
objective was to mimic the tetracysteinyl environment observed in Cd(II)-binding proteins active-
site. 125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The fourth cysteine residue was designed in two different locations (both in loop regions) in 
the sequence to compare the coordination capability of the two novel variants, the α3DIV-H72C 
and α3DIV-L21C peptides (Fig.1.11). As expected, the arrangement of the coordination 
environment was different in the two variants. The α3DIV-H72C peptide exhibited a CdS3O 
arrangement, while the α3DIV-L21C construct displayed a CdS4 first-sphere coordination 
environment due to the incorporation of a canonical C18XXC21 binding motif. 124 
The CdS4 coordination environment generated a redox inert species. Therefore, the Fe(II) and 
Fe(III) ions were rationally chosen to assess the possibility of creating a stable and redox active-
site, that is similar to the rubredoxin-like active-site with the same redox potentials of native 
rubredoxins. In fact, this Fe(Cys4)–α3DIV-L21C system have similar spectroscopic features and 
reduction potentials of its native counterpart 124. Such results reveal that is possible to design a 
rigid α-helical synthetic framework with a functional rubredoxin active-site instead of the flexible 
β-loop region found in natural rubredoxins. 123 
Cys67 
Cys28 
Cys21 
Cys72 
Cys67 
Cys28 
Cys21 
Cys18 
Figure 1.11. 3D structures of the a) α3DIV-L21C scaffold and b) α3DIV-H72C scaffold. The structures were 
modelled in the SWISS MODEL Workspace - ExPASy using the α3DIV scaffold (PDB: 2MTQ) as template. 
The images were visualised in Chimera1.11. 
a) b) 
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The Fe-α3DIV-L21C peptide was anaerobically reconstituted in a glove box using ferrous 
ammonium sulphate as an iron source. This procedure generated the reduced form of this 
peptide, the Fe(II)-α3DIV-L21C variant, that was oxidised to the Fe(III)-α3DIV-L21C form when 
exposed at the air. Both reduced and oxidised absorption spectrums were similar to the natural 
system in terms of S  Fe charge-transfer transitions, but the molar extinction coefficient values 
were three times smaller than in the native rubredoxin, meaning that the peptide structure have 
some influence in the intensity of these transitions. Additional magnetic circular dichroism 
spectroscopic studies revealed that the relative energies and polarizations of the thiolate → Fe(III) 
charge-transfer transitions were also similar to the native counterpart. Furthermore, the iron ion 
also contributes to the overall stabilization of the peptide structure. 124 
Such results showed that achievement of native-like metalloredox centres in non-natural folds, 
such in the present case of a CXXC motif embedded in an α-helical bundle, is possible and that 
the overall fold is not crucial for specific spectroscopic features. Rather, certain architectural 
features and precise ligand spatial coordination may be favoured over specific folds. Ultimately, 
incorporation of different biologically active metals into a generalized scaffold could tune these 
sites for alternative natural and non-natural catalytic functions. 
 
 
 
2. Aims 
2.1. General aims  
This thesis aims to incorporate a molybdenum atom within the rubredoxin-type metal-binding 
site of a de novo designed three-helix bundle peptide – apo-α3DIV-L21C. The tetracysteinyl 
active-site in a Mo-substituted synthetic peptide can mimic the tetrathiolate environment of the 
molybdenum-bis pyranopterin-guanosine dinucleotide-containing enzymes catalytic active-site in 
terms of ligand nature in the Mo first coordination sphere and spectroscopic features.  
Ultimately, this model system may be considered a structural and functional analogue for some 
Mo-bis PGD enzymes that have several biological roles and perform important metabolic 
reactions in the biogeochemical carbon, nitrogen and sulphur cycles. Such diversity in catalytic 
functions can be accomplished by the coordination of a wide range of ligands, such terminal oxo- 
or sulphur-atoms derived from exogenous ligands (e.g. =O, –OH, –OH2, =S, –SH) and/or from 
the protein’s polypeptide residues (e.g. serine, aspartate, cysteine, or selenocysteine). 
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2.2. Specific aims  
In order to consider this a de novo designed Mo-α3DIV-L21C peptide a structural and 
functional scaffold for some Mo-bis PGD enzyme, spectroscopic characterizations, thermal-
induced denaturation studies, bioelectrochemical studies and oxidation-reduction tests were 
performed. 
Spectroscopic studies included UV-vis spectroscopy, inductively coupled plasma atomic 
emission spectroscopy (ICP-AES) and circular dichroism (CD) spectroscopy. Such techniques 
allow a structural characterization and confirmation of the incorporation of a molybdenum atom 
within the rubredoxin-like metal-binding site of the α3DIV-L21C scaffold. Furthermore, through CD 
analysis we can inquiry about the secondary structure composition and rearrangement upon 
metal coordination, and speculate about modifications in the fingerprint of the tertiary structure. 
Thermal-induced characterization studies, like differential scanning calorimetry (DSC), 
estimate the specific thermodynamic parameters related to the unfolding process and examine 
the unfolding models that best described the α3DIV-L21C system. Electrochemical and reduction 
studies inquest about the oxidation state of the molybdenum atom, within the α3DIV-L21C 
scaffold, and analyse possible redox processes related with the metal physical-chemical 
proprieties. 
Ultimately, a comparison between the apo- and Mo-α3DIV-L21C peptides, in TCEP-induced 
reduction conditions and in a non-reducing environment, elucidate the crucial role of the 
tetracysteinyl environment in the peptide overall stability and in the metal incorporation. 
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2. Chapter 2. Materials and Methods 
2.1. Design of the apo-α3DIV-L21C peptide 
This project is a collaboration with Professor Vincent L. Pecoraro and co-workers from “De 
Novo Designing Coiled-Coil Peptide” laboratory group of the Department of Chemistry and 
Biophysics of the University of Michigan.  
The apo-α3DIV-L21C peptide was provided in the lyophilized form as a white powder. The 
production, purification and characterization of this synthetic peptide have been formerly 
described 124. The peptide primary sequence is “MGSWAEFKQRLAAIKTRCQACGGSEAE 
CAAFEKEIAAFESELQAYKGKGNPEVEALRKEAAAIRDECQAYRHN”. The calculated molecular 
mass and molar extinction coefficient of the apo-form is 8209.108 g.mol-1 and 8460 M-1.cm-1 
(ε280nm), respectively.  
 
 
2.2. Modelling the tetracysteinyl active-site in the α3DIV scaffold  
The three-dimensional structure of the apo-α3DIV-L21C peptide possessing a tetracysteinyl 
environment, as the metal-binding site, was obtained through homology modelling using the 
SWISS MODEL Workspace from ExPASy – SIB Bioinformatics Resource Portal. The input target 
sequence is described in the previous subsection (2.1.) and the template used for modelling was 
the PDB file – 2MTQ, which corresponds to the apo-α3DIV synthetic peptide.  
 
 
 
 
2 
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2.3. Molybdenum reconstitution: refolding in the absence of metal 
Note: The reconstitution procedure described below was done under aerobic and anaerobic 
conditions (MBraun UNIlab glovebox). Both conditions gave the same results.  
The molybdenum reconstitution of the α3DIV-L21C scaffold has achieved using the ammonium 
tetrathiomolybdate (TTM) compound was the precursor (Sigma-Aldrich, CAS Number 15060-55-
6, 99.97%). The TTM compound is a black-reddish powder that when solubilize gives rise to a 
strong-red colour specific of S  Mo charge-transfer transitions associated with the MoS42- form. 
The reconstitution procedure started with the preparation of a 250 μM solution of apo-α3DIV-
L21C in 50 mM Tris-HCl pH 7.6 buffer, containing 500 μM of the reducing agent TCEP (3,3′,3′′-
phosphanetriyltripropanoic acid) from Sigma-Aldrich (CAS Number 51805-45-9). A 10 mM TTM 
solution (metal solution) was prepared in 50 mM Tris-HCl pH 7.6 buffer, containing 20% v/v DMF 
(N, N-dimethylformamide), from Sigma-Aldrich (CAS Number 68-12-2, 99.8%), to help the metal 
solubilisation. The metal solution was stirred gently for 20 minutes. 
To optimize the reconstitution procedure several solutions of 250 μM of apo-peptide were 
incubated with different peptide: metal ratios to a final volume of 500 μL. The α3DIV-L21C:Mo 
ratios studied were 1:4, 1:6, 1:8, 1:9, 1:10 and 1:15. Two experimental sets were tested: five 
reaction mixtures were incubated at room temperature and other five at 50 ºC, in a dry hot air 
oven, for 2 hours, after the addition of the metal solution. 
Finished the incubation time, the samples were centrifuged, in a microcentrifuge from WVRTM 
International, for 10 minutes at 4500 g to remove any precipitate before loading the samples in a 
SephadexTM G-25 PD-10 desalting column, from GE Healthcare Life Sciences, that was 
previously equilibrated with 25 mL of 50 mM Tris-HCl pH 7.6 buffer without TCEP (equilibration 
buffer). The PD-10 column was used to remove any interfering compounds used in the 
reconstitution procedure, such as the TTM and TCEP compounds.  Each 500 μL samples were 
loaded into the column and eluted with 25 mL of the equilibration buffer. The Mo-reconstituted 
peptide elutes in volumes between 1.5 – 3 mL of equilibration buffer. The collected samples with 
the same UV-vis absorption profile were added to the same tube. The novel Mo-α3DIV-L21C 
peptide presents a yellowish colour. 
 
2.4. Metal quantification: ICP-AES analysis  
To obtain the molybdenum concentration, in reconstituted Mo-α3DIV-L21C peptide, elemental 
analysis was performed. An aqueous solution of 1 mL of Mo-peptide (final colour: yellowish-white) 
was analysed by Inductively Coupled Plasma – Atomic Emission Spectroscopy (ICP-AES), in an 
ICP Horiba Jobin-Yvon (Ultima) spectrometer, using the standard solution Reagecon 23 multi-
elements in a concentration range of 0.05 – 3 ppm.  
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2.5. Protein quantification: Lowry protein assay protocol 
To determine the peptide concentration a colourimetric Lowry protein assay was performed, 
using the bovine serum albumin (BSA) as a standard liquid solution (Sigma-Aldrich, CAS Number 
9048-46-8, 2 mg protein/mL). The Lowry quantification method employs two colourimetric 
reactions. The first one occurs when the Cu(II) atoms present in the Biuret reagent reacts with 
the peptide bonds, in alkaline conditions, resulting in the reduction of Cu(II) to Cu(I). The second 
reaction takes place when the phosphomolybdotungstate complex, present in the Folin-
Ciocaltaeu reagent, is reduced to heteropolymolybdenum blue due to the oxidation of aromatic 
residues catalysed by copper. The concentration of the reduced Folin-reagent is proportional to 
the protein concentration. (Fig. 2.1) 
The standard samples were made in duplicate and in a concentration range of 0 to 400 μg.mL-
1 of BSA. A standard curve of absorbance was plotted as a function of BSA concentration to 
determine the unknown peptide concentration. The colourimetric measures were done using a 
Shimadzu UV-1800 double-beam UV-VIS spectrophotometer at 750 nm (Table 2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The protocol initiates by adding 100 μL of each protein samples to a 15 mL falcon tube and 
addition of 400 μL of Biuret reagent (10 minute incubation time). Subsequently, 3.5 mL of 2.3% 
m/v sodium carbonate (Na2CO3) (Sigma Aldrich, CAS Number 497-19-8, 99.999%) and 100 μL 
of Folin-Ciocalteu´s phenol reagent (Sigma Aldrich, MDL Number MFCD00132625) were added 
to the 15 mL tube and the samples were gently mixed, in a vortex, and incubated for 30 minutes. 
Completed the incubation time, the absorbance of each standard and unknown samples was 
measured at 750 nm. 126 
 
Table 2.1. Absorbance measurements for each BSA concentration, at 750 nm. 
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2.6. Spectroscopic characterisation 
 
 Absorption spectroscopy 
The Ultraviolet-Visible spectroscopy was performed on a Shimadzu UV-1800 double-beam 
UV-VIS spectrophotometer and the spectra were visualised through an UVProve software. The 
spectra were recorded in 1 cm quartz cuvettes at slow speed and room temperature, with a scan 
pitch of 0.5 nm and a scan range from 250 to 800 nm.  
 
 Circular dichroism (CD) Spectroscopy 
Circular dichroism characterization was performed on an Applied Photophysics Chirascan™ 
qCD spectrometer. The CD data is either reported in millidegrees (mdeg) of ellipticity (θ) as a 
function of wavelength or is represented in mean residue ellipticity ([θ]MRE) as a function of 
wavelength 127–129. The [θ]MRE is the CD raw data corrected for the sample concentration (Equation 
2.1):  
 
[θ] (
deg. cm2
dmol
) =
θ (deg) ∗ MRW
10 ∗ L ∗ C
 
 
 
Figure 2.1. Standard calibration curve. At blue are the experimental Abs values. 
The dotted black line is the linear fit of the absorbance as a function of [BSA]. 
(Eq. 2.1) 
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To obtain information about the secondary structure composition, spectra for both apo- and 
Mo-α3DIV-L21C forms were recorded in the Far-UV region (190 – 260 nm) 130. For the Far-UV 
studies, the final samples of apo- and Mo-peptide forms were prepared in 10 mM Tris-HCl pH 7.6 
buffer with 0.5 mM of TCEP. The measurements were performed in a 1 mm path length cuvette 
with a total volume of 300 μL. The CD spectra presented are an average of three spectral 
acquisitions at 25 ºC, before and after the temperature cycle, with bandwidth and a step-size of 
1 nm. The temperature-dependent Far-UV CD spectra were performed in a temperature range of 
10 ºC to 94 ºC, with a stepped ramp mode of 0.4 seconds per point, a temperature increment of 
2 ºC for each measurement and a stabilization period of 1 second in each temperature, to 
estimate the midpoint of the unfolding process or melting temperature (Tm) in the Far-UV region 
131. 
Furthermore, information about the tertiary structure fingerprint (aromatic amino acids and 
disulphide bonds) 132 and metal-ligand interactions (L  M charge-transfer transitions or metal d–
d transitions) were also studied, exclusively, for the Mo-α3DIV-L21C form. These data were 
obtained by studying the near-UV region (260 – 320 nm) of the CD spectra and the visible region 
(320 – 600 nm) 133,134. For these studies, a sample of Mo-peptide form, with a concentration of 70 
μM, was prepared in 10 mM Tris-HCl pH 7.6 buffer with TCEP. The measurements were 
performed in a 10 mm path length quartz cuvette with a total volume of 2 mL. The CD spectra 
presented are an average of three spectral acquisitions at 25 ºC, before and after the temperature 
cycle, with bandwidth and a step-size of 1 nm. The temperature-dependent near-UV/visible CD 
spectra were performed in a temperature range of 19 ºC to 94 ºC, with a stepped ramp mode of 
0.3 seconds per point, a temperature increment of 3 ºC for each measurement and a stabilization 
period of 1 second in each temperature , to estimate the melting temperature (Tm) in the visible 
region. 
 
2.7. Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry characterization was performed in a TATM Nano DSC 
apparatus. DSC technique was used to characterize the stability and the folding process of the 
apo- and Mo-α3DIV-L21C forms 135–137. The thermodynamic parameters and melting temperature 
were obtained by fitting the thermograms in a NanoAnalyzeTM v3.10.0 Data Analysis software (TA 
Instruments).  
Normally, since proteins in solution are in equilibrium between folded (native) and unfolded 
(denatured) states, by heating the sample in a constant rate and, subsequently, measuring the 
heat change associated with intrinsic thermal denaturation processes, we can determine the 
calorimetric enthalpy (ΔHcal) and the change in heat capacity (ΔCp) of the unfolding process 138. 
Besides these thermodynamic proprieties, the DSC data also provides the Tm of the sample 
(maximum value). The Tm value correlates with the temperature at which the protein’s unfolded 
and folded states are in equal concentrations and is an indicator of the protein thermal stability.  
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Furthermore, the van’t Hoff enthalpy (ΔHVH) and the change in entropy (ΔS) are also indirectly 
provided by the DSC analysis, by analysing the shape of the thermogram 138. The ΔHVH measure 
the cooperativity of the transition, assuming a reversible two-state transition. In addition, the 
comparison of the ΔHcal with the ΔHVH is a method to verify the assumed two-state model used in 
the van’t Hoff calculations (ΔHVH/ΔHcal = 1). ΔHVH/ΔHcal ratios above 1 (one) may be an indication 
of self-association processes and ratios below 1 (one) is indicative of an unfolding process via 
one or more intermediate states. 138,139 
For these studies, the final samples of apo- and Mo-peptides were prepared in 50 mM 
phosphate buffer at pH 7.6 with 0.1 mM of TCEP. For these measurements were used 700 μL of 
each sample in concentrations of 0.4 mg/mL for the Mo-form and 0.5 mg/mL for the apo-form. 
The temperature range was -10 ºC to 130 ºC and the data were collected in an anaerobic Coy 
box atmosphere. 
 
2.8. Reducing tests  
Incubation studies were performed to speculate about the molybdenum oxidation state in the 
Mo-α3DIV-L21C scaffold. The reduction of the Mo atom, Mo(VI)  Mo(V)/Mo(IV), was tested by 
incubation with three reducing agents: 1,4-dithiothreitol (DTT) (Sigma Aldrich, CAS Number 3483-
12-3), sodium hydrosulphite (dithionite) (Sigma Aldrich, CAS Number 7775-14-6) and sodium 
ascorbate (Sigma Aldrich, CAS Number 134-03-2, ≥98%).  
The Mo-peptide was incubated with ascorbate and, consequently, purified in a PD-10 
desalting column, to remove the excess of ascorbate in solution since it absorbs in the visible 
region 140. Once DTT and dithionite mainly absorb in the ultraviolet region is not necessary to 
purify the samples in PD-10 column. All spectra were recorded on a Shimadzu UV-1800 double-
beam UV-VIS spectrophotometer and visualized through an UVProve software. 
To initiate the incubation experiment with DTT and dithionite, firstly, the Mo-α3DIV-L21C 
peptide (175 μM) was added to a 1 cm quartz cuvette. Solutions of the two reducing compounds, 
with a final concentration of 35 mM, were prepared to ensure a 1:1 stoichiometry using 5 μL of 
the solution. A total of 2 μL of DTT (0.4 equivalents) and 1 μL of dithionite (0.2 equivalents) was 
added to the cuvette and, in each addition, the solution was left incubate 5 min with a constant 
stir. The DTT test was performed aerobically and the dithionite test anaerobically, by partially 
degassing with N2 in a Schlenk line. 
In the incubation test with ascorbate, 116 μM of Mo-α3DIV-L21C peptide was added to a 1 mL 
eppendorf (Vfinal = 280 μL). A solution of ascorbate, with a final concentration of 580 μM, was 
prepared aerobically to achieve a 1:5 stoichiometry when 25 μL of the solution was added to the 
eppendorf (Vfinal = 280 μL). The solution was left incubate for 15 minutes and then passed in a 
PD-10 desalting column, equilibrated with 50 mM phosphate buffer at pH 7.6, to remove the 
excess of ascorbate. Fractions of 250 μL were collected in 1 mL eppendorfs, and the ones with 
the same absorption profile were combined. 
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2.9. Electrochemical characterization  
Electrochemistry is a technique that examines the interaction of electricity and a detectable 
chemical change by considering the movement of electric charges between an electrolyte and 
electrodes. This technique can be applied in biomolecules (e.g. enzymes) that can perform 
electrophysiological reactions to study their oxidation-reduction (redox) reactions. 141–145 
The electrochemical behaviour, of the apo- and Mo-α3DIV-L21C systems, was studied with a 
Potentiostat/Galvanostat Type III, using one compartment electrochemical cell. The experimental 
setup was performed in a GPES (General Purpose Electrochemical System) software. All the 
components are from Metrohm Autolab.  
To characterize the intrinsic electrocatalytic properties, thin layer cyclic voltammetry (TLCV) 
was performed in both apo- and Mo-peptides. The assays were performed inside a Faraday cage 
using a three electrode’s configuration in a single compartment electrochemical cell. The 
electrodes used were pyrolytic graphite (PG) as working electrode (4 mm), platine wire as 
counter-electrode and saturated calomel electrode (SCE) as a reference electrode. The potential 
values were obtained in SCE values, but the reported values are in the normal hydrogen electrode 
(NHE) reference (Eq. 2.2):  
 
E/V (vs. NHE) = E/V (vs. SCE) + 0.241 
 
 
Before each experiment, the PG electrode was previously polished with 0.3 and 1 μm 
micropolish alumina powder, from BUEHLER (Item Numbers: 40-10077 and 40-10079, 
respectively), then immersed in an ultra-sound bath (Millipore water) for 3 minutes and lastly 
thoroughly cleaned with Millipore water.  
For each experiment, 15 μL of apo-α3DIV-L21C (200 – 250 μM) or 15 μL Mo-α3DIV-L21C (50 
– 150 μM) were placed on the working electrode (WE). To enhance the electrochemical signal, 4 
μL of neomycin sulphate (2 mM) (Sigma Aldrich, CAS Number 1405-10-3) was also added to the 
WE. After coating the electrode, a solvent casting technique, at room temperature, was applied 
until it reached half of the initial volume. Consequently, a thin layer cellulose membrane with a 
3.5 kDa cut-off was positioned above the WE and immobilized with parafilm to entrap the peptide. 
The electrolyte solution (25 mL), prepared on the single electrochemical cell, consisted in 50 mM 
Tris-HCl buffer at pH 7.6 with 100 mM of NaCl, 20 mM neomycin sulphate and 500 μM of TCEP. 
Several scan rates, from 5 mV/s to 100 mV/s, were tested. The electrochemical measurements 
were performed in an anaerobic environment, provided by a glovebox ([O2]max = 3.5 ppm), and all 
the solutions (except the peptide solutions) were degassed with a continuous flow of argon, at 
least by 30 min, before were introduce in the anaerobic chamber. 
Besides the assay above, several conditions were tested to ensure a optimize result. Such 
conditions involved different pH’s (acetate buffer at pH 5.5; Tris-HCl buffer at pH 7.6; Tris-HCl 
(Eq. 2.2) 
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buffer at pH 8.5), reducing or non-reducing conditions (with or without TCEP) and aerobic or 
anaerobic environments.  Furthermore, three blanks were also tested “in solution” approach under 
anaerobic conditions. The blanks tested were: (I) 50 mM Tris-HCl buffer at pH 7.6 with 100 mM 
of NaCl, 20 mM neomycin sulphate and 500 μM of TCEP; (II) 50 mM Tris-HCl buffer at pH 7.6 
with 100 mM of NaCl, 20 mM neomycin sulphate and 150 μM of TTM compound and (III) 50 mM 
Tris-HCl buffer at pH 7.6 with 100 mM of NaCl and 20 mM neomycin sulphate. In these latter 
assays, the working electrode was coated with only 4 μL of neomycin sulphate (2 mM) and 
covered with a thin layer cellulose membrane (3.5 kDa cut-off). In this report, only the preliminary 
optimized result for the apo- and Mo-α3DIV-L21C peptides is revealed.  
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3. Chapter 3. Results and Discussion 
3.1. Modelling the structure of the apo-α3DIVL21C scaffold 
The three-dimensional structure of the apo-α3DIV-L21C peptide was modelled, with the 
SWISS MODEL Workspace, using as structural template the three-helix bundle α3DIV scaffold 
(PDB: 2MTQ). The primary sequence was modified through amino-acid substitution of a leucine 
residue by a cysteine in position 21 (L21C) (Table 3.1). This substitution led to the creation of a 
canonical rubredoxin-like CXXC motif with a tetracysteinyl environment as a metal-binding site. 
 
 
The model built presents a sequence identity of 98.63 % and a sequence similarity of 0.60 to 
the model template used. Besides, the model has a GMQE (Global Model Quality Estimation) of 
0.99 which indicates a high homology accuracy between the template and the model built (0 < 
GMQE < 1) 146. Furthermore, a QMEAN (Qualitative Model Energy ANalysis) of -0.85 
demonstrates a good agreement between the model and experimental structures of similar size 
(QMEAN close to zero) 147. 
Table 3.1. Primary sequences of α3DIV and α3DIV-L21C scaffolds. Cysteine residues are highlighted at 
blue. Amino acid substitution (L21C) is highlighted at red. 
Peptide scaffold Primary Sequence 
α
3
DIV MGSWAEFKQRLAAIKTRCQALGGSEAECAAFEKEIAAFESEL-
QAYKGKGNPEVEALRKEAAAIRDECQAYRHN 
α
3
DIV-L21C MGSWAEFKQRLAAIKTRCQACGGSEAECAAFEKEIAAFESEL-
QAYKGKGNPEVEALRKEAAAIRDECQAYRHN 
3 
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Since the only primary-sequence difference, between the α3DIV-L21C and α3DIV scaffolds, is 
a single mutation in position 21 and the SWISS MODEL scores obtain for the model quality eval-
uation are good, it seems that the amino acid substitution does not affect the overall peptide’s 
fold. (Fig. 3.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nevertheless, some differences appear in the distance values between the cysteine residues 
in the metal-binding site. The amino acid substitution (L21C), in the α3DIV scaffold, entails a 
decrease in the Cys18-Cys67, Cys28-Cys67 and Cys18-Cys28 distance values. Conversely, the 
distances between the Cys18-Cys21 and Cys21-Cys28 appear to increase, when are compared 
with the Cys18-Leu21 and Leu21-Cys28. The increase of the distance between the Cys18-Cys21 
and Cys21-Cys28 residues is explained by the residues side-chain size. Leucine residues create 
a greater spatial hindrance because of the larger side-chain (isobutyl group) that cysteines thiol 
side-chain. (Fig. 3.2) (Table 3.2) 
 
 
 
 
 
 
 
 
 
 
 
 
a) 
Cys18 
Cys67 Cys28 
Cys21 
b) 
Cys18 
Cys67 
Cys28 
Leu21 
Figure 3.2. Enlarged view of the apo-peptides metal-binding sites: (a) tetracysteinyl environment in 
the α3DIV-L21C peptide and (b) triscysteinyl environment in the α3DIV scaffold (PDB entry: 2MTQ). 
The residue distances were calculated and visualized in Chimera 1.11. 
C28 
C21 
C18 
C67 
a) 
C28 
C67 
C18 
L21 
b) 
Figure 3.1. Three-dimensional structures of the a) α3DIV-L21C and b) α3DIV scaffolds. The 
α3DIV-L21C was modelled in the SWISS MODEL Workspace from ExPASy, using the PDB 
entry: 2MTQ as template. The structures were edited in Chimera 1.11. 
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Table 3.2. Residue pairs distance presented in the cysteinyl metal-binding site of the α3DIV 
and α3DIV-L21C scaffolds.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The presence of the non-polar aliphatic side chain of leucine entails a slight hydrophobic 
character to the metal-binding site, which forces hydrophilic residues, such as cysteines, to depart 
from the binding site (Fig. 3.3). Ultimately, when the Leu was substituted by an amino acid with a 
polar-side chain (cysteine), the Cys18-Cys28-Cys67 residues can mutually stabilize through 
disulphide bonds and their spatial distance decreases.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Residue pairs 
Residue distances (Å) 
α3DIV scaffold 
Residue distances (Å) 
α3DIV-L21C scaffold 
 
Cys18-Cys67 3.58 3.42  
Cys28-Cys67 5.46 5.29  
Cys21-Cys28 – 4.62 
 
Leu21-Cys28 3.67 – 
Cys18-Cys21 – 5.63 
 
Cys18-Leu21 5.14 – 
Cys18-Cys28 6.69 6.47  
a) b) 
Figure 3.3. Amino acid hydrophobicity in the (a) α3DIV-L21C and (b) α3DIV (PDB entry: 2MTQ) scaf-
folds. Most hydrophilic residues are highlighted at green and the most hydrophobic residues at orange. 
The molecular surface was coloured using the Kyte-Doolittle scale in Chimera 1.11. 
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3.2. Molybdenum reconstitution and UV-vis characterization  
The refolding of the apo-α3DIV-L21C peptide was performed in TCEP-induced reducing 
conditions to prevent the formation of disulphide bonds, by oxidation of cysteine residues, and to 
enhance the metal incorporation. Subsequently, the peptide incubation with different 
concentrations of tetrathiomolybdate was accomplish by fixing 6 peptide: metal ratios, 
1peptide:4Mo, 1peptide:6Mo, 1peptide:8Mo, 1peptide:9Mo, 1peptide:10Mo and 1peptide:15Mo. 
The reconstitution procedure was attempted at room temperature and at 50 ºC, with long 
incubation times and under aerobic and anaerobic conditions. All the experimental sets given the 
same incorporation results. In Fig. 3.4 are represented the UV-visible spectra obtain, under 
aerobic conditions at room temperature, and the spectral development achieved by the interaction 
of the Mo atom with the tetracysteinyl environment in the metal-binding site. 
 
 
 
 
 
These results demonstrate that increasing the molybdenum concentration enhances the metal 
incorporation in the apo-α3DIV-L21C scaffold. The appearance of two unresolved shoulders 
between 300-330 nm and 450-475 nm, characteristic of thiolate-Mo charge-transfer bands 89,91,92, 
confirm the Mo incorporation. These transitions are similar to the ones observed in the UV-vis 
spectrum of the free TTM compound, which has spectral maximums at 318 and 469 nm (Fig.3.4. 
inset) 
Figure 3.4. UV-visible spectra of the peptide: metal ratio tested. Each reconstitution procedure was 
carried in 50mM Tris-HCl buffer at pH 7.6 with 0.5 mM TCEP. The experiment was performed at 
room temperature under aerobic conditions. Spectra were normalised to protein concentration. In 
inset is the UV-vis spectrum of the TTM compound. 
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Furthermore, by observing the spectral development, the system reaches stabilization at 1:8, 
1:9 and 1:10 ratios (Fig.3.5). These results are confirmed by the λ320/λ277 absorbance ratios, which 
also stabilize at 0.608, 0.603, and 0.636 for the 1:8 and 1:9 and 1:10 ratios, respectively. In 
peptide: metal stoichiometry above 1:10, the absorbance ratio intensely increases, which 
suggests an unspecific interaction of the metal with the peptide scaffold. These unspecific 
interactions may arise from electrostatically interactions in the peptide surface instead of 
coordination with the cysteinyl sulphurs in the metal-binding site. This deduction is further 
corroborated by the incorporation ratios estimated by Lowry an ICP quantification. (Table 3.3) 
 
 
 
 
 
Reconstitution ra-
tio peptide:metal 
[α3DIV-L21C] by 
Lowry method (μM) 
[Molybdenum] by 
ICP analysis ( μM) 
Incorporation ratio 
[Mo]/[peptide] 
λ
320
/λ
277
 
ratio 
1.4 40.6 7.46 0.18 0.252 
1:6 46.6 24.1 0.52 0.448 
1:8 41.6 44.0 1.06 0.608 
1:9 33.0 33.6 1 0.603 
1:10 45.5 61.0 1.32 0.636 
1:15 36.9 104.0 2.8 0.743 
Table 3.3. Incorporation ratios determine for each reconstitution ratio tested. 
Figure 3.5. Variation of the λ320/λ277 ratio values as a 
function of the different metal to protein ratios tested.  
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The reconstituted Mo-α3DIV-L21C (or holo-α3DIV-L21C) presents an absorption maximum at 
277 nm (ε = 12000 M-1.cm-1) and two unresolved shoulders at 320 nm (ε = 7400 M-1.cm-1) and 
470 nm (ε = 2000 M-1.cm-1). These transitions are very similar to the ones obtain in the 
molybdenum-substituted rubredoxins (Mo-Rd), redesigned by Maiti et al. In this case, the Mo-Rd 
system demonstrated an absorption maxima at 278 nm (ε = 17770 M-1.cm-1) and two unresolved 
shoulders at 314 (ε = 8010 M-1.cm-1) and 450 nm (ε = 1020 M-1.cm-1) 52. These results were 
expected because in both systems (Mo-α3DIV-L21C and Mo-Rd), the molybdenum atom 
coordinates in the same tetracysteinyl environment provided by a rubredoxin-like motif and, so, 
Mo-thiolate charge-transfer bands appear.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From these data, we conclude that this is an effective approach to coordinate a Mo atom in 
the α3DIV-L21C scaffold. Quantification data reveal a 90% reconstitution efficiency in ratios of 
1peptide:8/9Mo atoms and UV-vis spectral analysis confirm the metal coordination in the 
specifically-designed rubredoxin-like metal-binding site. In ratios above 1peptide:10Mo atoms, 
unspecific electrostatic interactions of the molybdenum atom with the positive residues, histidine 
(His), lysine (Lys) and arginine (Arg), in the peptide surface emerge. (Fig. 3.6) 
Moreover, to achieve the metal incorporation it is necessary excess of molybdenum atoms (8-
9x superior) relatively to the peptide concentration. This requirement is explained by the relative 
position of the rubredoxin-like active-site which, in the α3DIV-L21C scaffold, is positioned in a rigid 
three α-helices bundle and, in the rubredoxin structure, is located in a flexible β-loop region 148 
that provides more degrees of freedom to the protein structure and, consequently, the metal-
binding site. (Fig. 3.7) 
 
 
 
C28 C21 
C18 
C67 
Lys 
His 
Arg 
Figure 3.6. Positive charged amino acids in the α3DIV-L21C scaffold. Side-
chains of arginine residues at purple, of histidine residues at magenta and of 
lysine residues at hot pink. Side-chain of cysteine residues at yellow. 
Structures were edited in Chimera 1.11. 
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3.3. Circular dichroism (CD) characterization 
 
 Far-UV absorption CD characterization  
Circular dichroism studies, in the Far-UV region (190 – 260 nm), provide important information 
about the typology and the content of a protein/peptide secondary structures 127,129. The far-UV 
spectra for both apo-α3DIV-L21C and Mo-α3DIV-L21C forms confirm the helical structure 
conformation of the α3DIV-L21C scaffold. The presence of one broad transition at 222 nm (n→π*) 
and one positive maximum at 195 nm (π→π*) indicate a typical α-helical system as expected 130. 
Furthermore, the [ϴ]222/[ϴ]208 ratios close to 1 (one) support the α-helical character of both forms 
and reveal that the incorporation of a molybdenum atom within the metal-binding site does not 
affect the secondary structure profile. (Fig. 3.8) 
To test the thermal stability of both apo- and holo-systems and, ultimately, estimate the melting 
temperature, a temperature ramp, from 10 ºC to 90 ºC, was performed. The spectra in each case 
follow a similar denaturation profile that is, as the temperature increases, the CD signals at 222 
and 208 nm approaches to 0 (zero), which indicates a thermally-induced denaturation of the 
secondary structure (Fig. 3.9 and 3.10).  
 
 
 
 
 
C67 
C21 
C28 
C18 
C9 
C6 
C42 
C39 
a) b) 
Figure 3.7. Comparison of secondary structures composition between (a) apo-α3DIV-L21C scaffold and 
(b) rubredoxin from D. gigas (PDB: 2DSX). α-helices highlighted at red; β-sheets at salmon and coiled 
coils at grey. Structures were edited in Chimera 1.11. 
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Figure 3.8. CD average spectra, in the far-UV region, of the apo- and 
Mo-α3DIV-L21C peptides before the temperature cycles. The spectra 
were collected in 10 mM Tris-HCl pH 7.6 buffer, with 0.5 mM TCEP, in 
a 0.1 cm pathlength cuvette at 26 ºC. 
Figure 3.9. Temperature cycles (from 10°C to 90°C) of apo-α3DIV-L21C peptide in 
the far-UV region. Spectra were collected in 10 mM Tris-HCl pH 7.6 buffer, with 0.5 
mM TCEP, in a 0.1 cm pathlength cuvette with a stepped ramp mode of 0.4 seconds 
per point. The temperature increment was 2 ºC for each spectra with a stabilization 
period of 1 second in each temperature. 
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The loss of secondary structure is consistent with the decrease of the [ϴ]222/[ϴ]208 ratio values 
calculated at 90 ºC. Additionally, the CD spectra of both systems after the temperature cycle (at 
26 – 30 ºC) displays a regain in the secondary structure profile, with the characteristic CD signals 
at 208 and 222 nm (Fig. 3.11), and a [ϴ]222/[ϴ]208 ratios close to one.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10. Temperature cycles (from 10 °C to 90 °C) of Mo-α3DIV-L21C peptide in 
the far-UV region. Spectra were collected in 10 mM Tris-HCl pH 7.6 buffer, with 0.5 
mM TCEP, in a 0.1 cm pathlength cuvette with a stepped ramp mode of 0.4 seconds 
per point. The temperature increment was 2 ºC for each spectra with a stabilization 
period of 1 second in each temperature. 
Figure 3.11. CD average spectra, in the far-UV region, of the apo- 
and Mo-α3DIV-L21C peptides after the temperature cycles. The 
spectra were collected in 10 mM Tris-HCl pH 7.6 buffer, with 0.5 mM 
TCEP, in a 0.1 cm pathlength cuvette at 26 °C. 
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Interestingly, by comparing the [ϴ]222/[ϴ]208 ratios of the apo- and Mo-α3DIV-L21C peptides 
with and without TCEP, it is possible to conclude that a presence of a reducing agent promotes 
a more accentuated thermal destabilization in the secondary structure (Table 3.4). This behaviour, 
in the absence of TCEP, can be explained by the formation of disulphide bridges between the 
four cysteine residues, in the metal-site after metal losing, which imposes a more thermally robust 
scaffold even at 90 ºC. In TCEP induced reducing conditions, the cysteines are being reduced, 
which prevents the formation of SS-bonds and further destabilizes the secondary structure. Fur-
thermore, in each case, the apo-peptide retains more its folded secondary structure, which indi-
cates higher thermal stability. 
 
 
To determine the thermodynamic parameters, such as the melting temperature (Tm) and the 
enthalpy of folding (ΔH), the variation in mean residue ellipticity ([ϴ]MRE) at 222 nm as a function 
of temperature was plotted for both apo- and Mo-α3DIV-L21C forms in the presence of TCEP. 
The theoretical data was calculated and fitted to the experimental data using the equations for a 
two-state transition of a monomer from a folded to unfolded state, that assumes an equal heat 
capacity (ΔCp) for both states (Equations 3.1, 3.2 and 3.3). 131 
 
 
(3.1)       f = ((u − l) ∗ y) + l 
 
(3.2)       y =  
k
1 + k
 
 
(3.3)      k =  e
(
h
1.987∗t
)∗((
t
m
)−1)
 
 
 
 
Table 3.4. Comparison between [ϴ]222/[ϴ]208 ratios for apo- and Mo-α3DIV-L21C at 10 °C, 50 ºC, 
90 °C and after the temperature ramp. The ratios in the absence of TCEP were retrieved from 152. 
  Sample 
[ϴ]
222
/[ϴ]
208
 
10 ºC 
[ϴ]
222
/[ϴ]
208
 
50 ºC 
[ϴ]
222
/[ϴ]
208
 
90 ºC 
[ϴ]
222
/[ϴ]
208
 
25 ºC * 
With 
TCEP 
Apo-α
3
DIV-L21C 1.05 0.92 0.49 0.96 
Mo-α
3
DIV-L21C 0.98 0.91 0.36 0.91 
Without 
TCEP 
Apo-α
3
DIV-L21C 1.00 0.84 0.81 1.00 
Mo-α
3
DIV-L21C 0.97 0.82 0.63 0.94 
* After temperature ramp. 
k = folding constant at any given temperature    (cal.mol-1.K-1) 
y = fraction folded at any given temperature 
f = ellipticity at any given temperature            (deg.cm2.dmol-1) 
l = [θ] of unfolded protein             (deg.cm2.dmol-1) 
u = [θ] of 100% folded helical protein            (deg.cm2.dmol-1) 
h = starting enthalpy               (cal.mol-1) 
t = given temperature               (K) 
m = melting temperature              (K) 
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The melting temperature estimated for both apo- and Mo-α3DIV-L21C forms (in the presence 
of TCEP), regarding the peptide’s secondary structure, were extremely similar, being 60.0 ºC and 
60.3 ºC, respectively. Such results reveal that the secondary structure remains in its original fold 
even if a molybdenum atom is incorporated in the tetracysteinyl metal-binding site. Furthermore, 
the enthalpy of folding (ΔH) was also estimated for both peptide forms, the apo-peptide have a 
ΔH of -100.6 kJ.mol-1 (-24.0 kcal.mol-1) and the Mo-peptide a ΔH of -80.9 kJ.mol-1 (-19.3 kcal.mol-
1). (Fig. 3.12 and 3.13) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12. Variation of the mean residue ellipticity ([ϴ]MRE) at 222 nm as a function of 
temperature apo-α3DIV-L21C peptide (at blue), in the presence of TCEP. The experimental 
data were fitted using the equations for a two-state transition (solid black line). 
Figure 3.13. Variation of the mean residue ellipticity ([ϴ]MRE) at 222 nm as a function of 
temperature Mo-α3DIV-L21C peptide (at orange), in the presence of TCEP. The 
experimental data were fitted using the equations for a two-state transition (solid black line). 
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These results suggest that the α3DIV-L21C scaffold releases energy in the folding process by 
the formation of hydrogen bonds, ionic salt bridges and Van der Waals forces. These enthalpic 
contributions, at lower temperatures, outweigh the entropic contributions provided by the 
hydrophobic interactions, leading to a spontaneous folding process. Conversely, at higher 
temperatures, the entropic effects are more prominent, leading to an energetically-favourable 
unfolding process 149,150. These results were expected since the α3DIV scaffold was carefully 
constructed to spontaneously fold by virtue of hydrophobic interactions 113.  
Nevertheless, a ΔH value differentiation of ≈ -20 kJ.mol-1 for both apo- and Mo-peptides 
suggest that the incorporation of a molybdenum atom within the metal-binding promotes a small 
destabilization in the secondary structure, leading to a slightly less spontaneous folding process. 
These results diverge from the ones obtain in the incorporation of the iron atom in the α3DIV-
L21C scaffold. In this case, the Fe-coordination in the tetracysteinyl environment does not alter 
significantly the enthalpy of folding (ΔHapo-α3DIV-L21C = 140.9 kJ.mol
-1; ΔHFe-α3DIV-L21C = 143.7 
kJ.mol-1) 124. The difference observed may be explained by the fact that molybdenum has a higher 
atomic radius than iron (190 pm for Mo; 156 pm for Fe) and, therefore, for the smaller Fe atom 
the access and coordination on the metal-binding site are more favourable in terms of intrinsic 
peptide structural hindrance 151,152. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14. Variation of the mean residue ellipticity ([ϴ]MRE) at 222 nm as a 
function of temperature apo-α3DIV-L21C peptide (at black), in the absence 
of TCEP. The experimental data were fitted using the equations for a two-
state transition of a monomer from a folded to unfolded state, assuming an 
equal heat capacity for both states (solid red line). Remove from 153. 
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Preliminary CD studies for Tm and ΔH determination, of both apo- and Mo-α3DIV-L21C forms 
without TCEP-induced reducing conditions, failed to promote stabilization in the resultant trending 
curve of the fitted data and, therefore, precluding the determination of the thermodynamic 
parameters 153 (Fig.3.14). Such results might be explained by the formation of inter-disulphide 
bonds between several α3DIV-L21C scaffolds, which leads to various structural oligomers. In the 
presence of TCEP, the formation of S-S bonds is prevented leading to a unique structural 
conformation of the α3DIV-L21C scaffold.  
 
 
 Near-UV absorption CD characterization  
Circular dichroism studies in the near-UV region provide a “fingerprint” of the protein tertiary 
structure 129. The contributions in the near-UV region arise from transitions in the environment of 
each aromatic residue side chain, such as tryptophan, tyrosine and phenylalanine. Besides, 
contributions from disulphide bonds may also appear but the intensity of the transition is much 
weaker than the aromatic amino acid contributions. 132,154 
The α3DIV-L21C scaffold contains six aromatic residues in its primary sequence: two tyrosine 
(Tyr) residues, one in the C-terminal region, and one tryptophan (Trp) residue in the N-terminal 
region, all exposed to the solvent, and three phenylalanine (Phe) residues embedded in the 
hydrophobic core (Fig. 3.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trp4 
Tyr45 
Tyr70 
Phe7 
Phe38 
Phe31 
Trp4 
Tyr45 
Tyr70 
Phe31 
Phe38 
Phe7 
Figure 3.15. Aromatic amino acids in the α3DIV-L21C scaffold. Tryptophan residue at red, 
tyrosine residues at green and phenylalanine residues at orange. Side-chain of cysteine 
residues at yellow. Structure was edited in Chimera 1.11. 
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In Fig.3.16 is the near-UV spectral comparison of the apo and Mo-α3DIV-L21C peptides in the 
absence of TCEP. The CD spectra of both forms present some differences related to the 
sharpening and definition of the peak contributions. In both cases, the negative intensity peaks 
between 260 – 270 nm could be attributed to the phenylalanine contributions. The tyrosine 
contributions appear between 275 and 285 nm and the broad positive peak between 290 – 292 
nm can be attributed to the unique tryptophan residue. The assignment of sharp intensity peaks 
with specific aromatic side-chain contributions is not as straightforward as it seems since the 
contributions of Phe – Tyr and Tyr – Trp may overlap. 129 
 
 
 
Nevertheless, a broader near-UV spectral profile, in the apo-peptide, may suggest additional 
spectral contributions, possibly from a disulphide-bonds formation within the tetracysteinyl 
environment. Although, the spectrum from the apo-scaffold is less sharp and defined that the Mo-
counterpart, the overall peak profile is very similar which indicate some smaller changes in the 
tertiary structure upon metal-binding. 
Figure 3.16. CD spectra overlap of apo- and Mo-α3DIV-L21C peptides (70 μM), in non-
reducing conditions. Spectra were collected in 10 mM Tris-HCl pH 7.6 buffer in a 10 mm 
pathlength cuvette at 20 °C. 
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Furthermore, the near-UV spectra of Mo-α3DIV-L21C peptide in TCEP-induced reducing and 
non-reducing conditions were also compared (Fig.3.17). Both spectra present a similar peak 
profile however, in a reducing environment, the aromatic amino-acid contributions appear more 
sharpened and defined. This behaviour may be explained by changes in the environment of each 
side chain residues, such as additional hydrogen bonding and electrostatic interactions, and 
polarizability effects, induced by the reducing agent TCEP 112,114,137,156. As expected, such 
interactions seem to have a higher influence in the Tyr – Trp spectral contributions region (275 – 
292 nm), since the side chains of this two aromatic residues are exposed to the solvent. 
Nonetheless, in non-reducing conditions, the formation of disulphide bridges, within the 
tetracysteinyl environment, may also account to the spectral broadening. These results suggest 
the presence of a reducing agent do not promote significant alterations on the overall tertiary 
structure fingerprint but change the surrounding side-chain environment in some aromatic 
residues. 
 
 
 
 
 
 
 
Figure 3.17. CD spectra overlap of Mo-α3DIV-L21C peptide (70 μM), in non-reducing and 
TCEP-induced reducing conditions. Spectra were collected in 10 mM Tris-HCl pH 7.6 buffer, 
with or without 0.5 mM of TCEP, in a 10 mm pathlength cuvette at 20 °C. 
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 Visible absorption CD characterization 
Circular dichroism studies in the visible region are useful in systems holding charge-transfer 
transitions originated from metal-ligand complexes 133,134,157, like in the Mo-α3DIV-L21C scaffold 
that comprises a molybdenum atom coordinated in a tetracysteinyl environment (Mo-thiolate 
transitions). This coordination imposes a chiral environment in the metal-binding site with a 
specific CD signal in the visible region. 
The CD data from the Mo-α3DIV-L21C scaffold, in the presence of TCEP, exhibits an intense 
absorption band with a maximum at 392 nm (Fig. 3.18). This spectral contribution in the visible 
region and the absence of a CD signal from tetrathiomolybdate supports the successful 
incorporation of the Mo atom in the rubredoxin-like metal-binding site.  
 
The thermal stability in the visible region was also evaluated. The spectra exhibit a loss in the 
characteristic CD signal ([ϴ] close to zero) as a consequence of thermal-induced denaturation of 
the secondary structure (Fig.3.19). The thermodynamic parameters (Tm and ΔH) were also esti-
mated by fitting the experimental data to the equations for a two-state transition of a monomer 
from a folded to unfolded state used in the previous section (Eq. 3.1, 3.2 and 3.3) 131. The variation 
in mean residue ellipticity ([ϴ]MRE) was followed at 392 nm as a function of temperature. The Mo-
α3DIV-L21C peptide has an estimated melting temperature of 73.6 ºC and the enthalpy of the 
folding of -125.9 kJ.mol-1 (-30.1 kcal.mol-1) (Fig. 3.20). The parameters determined, reveals two 
parallel denaturation behaviours in the α3DIV-L21C scaffold, one in the rubredoxin-like metal-
binding site and the second one in the overall secondary structure. 
Figure 3.18. CD average spectra, in the visible region, of the Mo-α3DIV-L21C peptide (black 
solid line) and of the tetrathiomolybdate compound (blue solid line). The spectra were collected 
in 10 mM Tris-HCl pH 7.6 buffer, with 0.5 mM of TCEP, in a 10 mm pathlength cuvette at 26 ºC. 
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These results suggest that the secondary structure undergo an initial thermal-induced 
denaturation (at 60 ºC) prior to the loss of the molybdenum-thiolate coordination complex (at 74 
ºC). Such behaviour implies that the rubredoxin-like metal-binding site is more stable to an 
Figure 3.19. Temperature cycles (from 19 °C to 94 °C) of Mo-α3DIV-L21C peptide in the 
visible region. Spectra were collected in 10 mM Tris-HCl pH 7.6 buffer, with 0.5 mM TCEP, 
in a 10 mm pathlength cuvette with a stepped ramp mode of 0.3 seconds per point. The 
temperature increment was 3 ºC for each spectra with a stabilization period of 1 second in 
each temperature. 
Figure 3.20. Variation of the mean residue ellipticity ([ϴ]MRE) at 392 nm as a function 
of temperature for the Mo-α3DIV-L21C peptide. The experimental data was fitted 
using the equations for a two-state transition of a monomer from a folded to unfolded 
state, assuming an equal heat capacity for both states (solid black line). 
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increase in temperature than the overall secondary structure and that the [Mo(SCys)4] site does 
not control the thermal-stability of the native fold of the α3DIV-L21C scaffold 158,159. Furthermore, 
an estimated ΔH value of -125.9 kJ.mol-1 suggests that the coordination of the molybdenum atom 
by cysteine residues occurs spontaneously. Nevertheless, the estimation of these thermodynamic 
parameters is affected by an experimental error from the impossibly of achieving a plateau region 
at higher temperatures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21. CD average spectra, before and after the T cycles, of the Mo-α3DIV-
L21C peptide in reducing conditions. The spectra were collected in 10 mM Tris-HCl 
pH 7.6 buffer with 0.5 mM TCEP, in a 10 mm pathlength cuvette at 26 ºC. 
Figure 3.22. CD average spectra, before and after the T cycles, of the Mo-α3DIV-
L21C pep-tide in non-reducing conditions. The spectra were collected in 10 mM 
Tris-HCl pH 7.6 buffer, in a 10 mm pathlength cuvette at 26 ºC. 
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Subsequently, to the temperature cycles, the CD spectra of the Mo-α3DIV-L21C peptide, in 
TCEP-induced reducing conditions, was collected again at 26 ºC. The data in the visible region 
displays a regain of the positive intensity with a maximum at 385 nm (Fig. 3.21). This wavelength 
is distinct to the one observed before the temperature ramp (392 nm). Such results suggest that 
the metal coordinates again to the peptide but some differences in the metal coordination may be 
observed such as the metal being coordinated only by one, two or three cysteine residues before 
reaching an equilibrium that leads to the coordination in a tetracysteinyl environment. The UV-vis 
spectra collected before and after the temperature cycles further confirm the formation of other(s) 
Mo-thiolate specie(s) distinct(s) from the initial MoS4
2- compound (Fig. 3.23). Interestingly, the CD 
spectra of Mo-α3DIV-L21C form, in non-reducing conditions, do not show a regain of the signal 
which confirms the role of the reducing agent in preventing the formation of disulphide bridges 
(Fig. 3.22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4. Differential Scanning Calorimetry (DSC) characterization 
DSC studies on the Mo-α3DIV-L21C scaffold, under reducing conditions, was performed to 
study the peptide thermal stability and determine thermodynamic parameters, such as the melting 
temperature (Tm), the calorimetric enthalpy (ΔHcal), the Van’t Hoff enthalpy (ΔHvH) and the ΔHvan’t 
Hoff/ΔHcal ratio (ΔHvH/ΔHcal) 138,139,160. The DSC thermograms of the Mo-peptide fitted well to a 
reversible monomeric (one-peak) two-state model. 161 
 
Figure 3.23. UV-vis spectra collected before and after the temperature ramp for 
the Mo-α3DIV-L21C peptide ([peptide] = 70 μM). 
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In TCEP-induced reducing conditions, the Mo-α3DIV-L21C peptide exhibit a melting 
temperature of 66.1 ºC, a ΔHcal value of 846.4 kJ.mol-1 (202.2 kcal.mol-1) and a ΔHvH value of 
920.0 kJ.mol-1 (219.8 kcal.mol-1) (Fig. 3.24). The midpoint transition determined by the DSC 
technique is distinct from the ones estimated by the CD studies, which estimated a Tm of 60.3 (in 
the far-UV region) and 73.6 (in the visible region). The Tm value estimated, from DSC analysis, 
suggests that the tertiary structure starts undergoing an unfolding process in the temperature 
range from 60 – 70 ºC. Nevertheless, both CD and DSC techniques established a comparable 
monomeric two-state transition from a folded- to an unfolded-state. 
 
 
 
 
Furthermore, a ΔHvan’t Hoff/ΔHcal ratio of 1.09 (ΔHvH/ΔHcal = 1) further supports the unfolding 
process via a reversible monomeric two-state transition. However, a ΔHvH/ΔHcal value > 1 may 
reveal or a small self-association upon temperature increasing, through inter-disulphide bridge 
formation, or an over-estimation of the peptide concentration (Table. 3.5) 138,139.  
 
 
 
 
 
 Table 3.5. Thermodynamic parameters estimated for the Mo-α3DIV-L21C peptide in TCEP-
induced reducing conditions. 
  Sample Tm (ºC) 
ΔHcal 
(kJ.mol
-1
) 
ΔHvH 
(kJ.mol
-1
) 
ΔH
vH
/ΔH
cal
 ratio 
With 
TCEP 
Mo-α
3
DIV-L21C 66.10 846.4 920.04 1.09 
Δ
C
p
 (
k
J
.m
o
l-1
.K
-1
) 
Temperature (ºC) 
Raw Data 
Model Sum: monomeric 
two-state model 
Figure 3.24. DSC thermogram of Mo-α3DIV-L21C peptide (0.4 mg.mL
-1) in 50 mM phosphate buffer at 
pH 7.6, in the presence of 0.1 mM TCEP. The data was fitted, with a reversible one-peak two-state 
model, and visualised using the NanoAnalyse v3.10.0 software. 
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Unfortunately a DSC thermogram of the apo-α3DIV-L21C scaffold, in the presence of reducing 
agent, was not obtained. The collect thermogram shows a large multiplicity of signals which 
preclude correct data fitting and, consequently, the determination of thermodynamic parameters 
(Fig.3.25). This behaviour confirms that the tetracysteinyl environment has an important role in 
determining the arrangement of the tertiary structure. This obstacle may be sorted out by a 
titration test with different concentrations of the TCEP compound, in order to define the correct 
peptide: reducing agent stoichiometry without introducing experimental errors related with the 
contribution of the TCEP to the overall analysis of the thermodynamic parameters or with cross-
reactions of the reducing agent with the phosphate buffer 162. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Previous studies of the incorporation of three heavy metal, such as Hg, Cd, and Pb, within 
the triscysteinyl site of the α3DIV scaffold show an increase of the Tm values (18−24 °C) when the 
metal is coordinated, suggesting higher thermal stability for the metallated scaffolds 118. 
Furthermore, the α3DIV peptide displays a pH-dependent behaviour that impacts the 
determination of the thermodynamic parameters. In neutral pH (pH = 7) the α3DIV peptide exhibit 
a midpoint transition at 64.4 ºC and in alkaline pH (pH = 8.2) exhibit at 60.2 ºC 118. In the present 
case, a comparison between the apo- and Mo-peptide forms was not achieved and, consequently, 
a direct correlation, at this stage, of the effects of incorporation of a Mo atom, in the 
thermodynamic proprieties of the α3DIV-L21C scaffold, it is inexact.  
Nonetheless, this preliminary analysis demonstrates the role of the reducing agent in 
preventing the creation of several structural variants that difficult the analysis of the DSC data, 
due to oligomerization effects. Further DSC analysis of the apo-α3DIV-L21C, in the presence of 
the reducing agent, must be made to enable a good correlation between the data from the α3DIV 
and α3DIV-L21C metallated and unmetallated systems. 
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Figure 3.25. DSC thermogram of apo-α3DIV-L21C peptide (0.5 mg.mL-1) in 50 mM phosphate buffer 
at pH 7.6, in the presence of 0.1 mM TCEP. The data was visualised using the NanoAnalyse v3.10.0 
software. 
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3.5. Oxidation-state characterization: Reducing tests 
Incubation studies were performed to assess the metal oxidation state when the Mo atom is 
coordinated in the tetracysteinyl environment of the α3DIV-L21C scaffold. To test the reduction of 
the metal, three incubations were done using the reducing agents 1,4-dithiothreitol (DTT) and 
sodium ascorbate, under aerobic conditions, and sodium hydrosulphite (dithionite) in an 
anaerobic environment. The incubation test with ascorbate does not alter the UV-vis spectral 
profile of the Mo-peptide (Fig.3.26), but the tests with 0.4 equivalents of DTT and 0.2 equivalents 
dithionite provided similar results (Fig.3.27 and 3.28).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An absorbance increase in the Mo-thiolate charge-transfer spectral region (300 – 340 nm) 
suggests a higher contribution of charge-transfer transitions. This increase may be a 
consequence of the metal reduction, from Mo(VI) to Mo(V), or additional coordination of the metal 
with a sulphur atom of an exogenous thiol compound 52,163,164. The latter behaviour was also 
observed in the DTT-treated Mo-rubredoxin derivative, where the appearance of a UV-vis band 
at 336 nm (ε = 7.76 mM−1.cm−1) and at 460 nm (ε = 1.91 mM−1.cm−1) may suggest the coordination 
of sulphur from an exogenous thiol ligand in the Mo-centre 52. 
 
Figure 3.26. UV-visible spectra of the incubation test with 5 equivalents of sodium 
ascorbate, under aerobic conditions. The incubation was performed in 50mM Tris-HCl 
buffer at pH 7.6. Spectra were normalised to protein concentration. 
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Figure 3.27. UV-visible spectra of the incubation test with 0.4 equivalents of DTT, 
under aerobic conditions. The incubation was performed in 50mM Tris-HCl buffer at 
pH 7.6. Spectra were normalised to protein concentration. 
Figure 3.28. UV-visible spectra of the incubation test with 0.2 equivalents of sodium 
dithionite, under anaerobic conditions. The incubation was performed in 50mM Tris-
HCl buffer at pH 7.6. Spectra were normalised to protein concentration. 
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By correlating these data with the electrochemical studies (in the next section), that estimated 
a midpoint potential of -406 mV vs. NHE at pH 7.6, these results suggest that DTT is not able to 
reduce the Mo atom since the reduction potential of DTT is -330 mV vs. NHE at pH 7 and, 
therefore, probably as in Rd the DTT is providing a transient additional coordination 165. Contrarily, 
dithionite has a higher reducing power (-660 mV vs. NHE at pH = 7 166) than DTT, which indicate 
that the Mo-centre can only be reduced with dithionite. This interpretation is further supported by 
the fact that the UV-vis spectral profile of the Mo-α3DIV-L21C scaffold remains identical when 
treated with 0.4 – 1.2 equivalents of DTT (data not shown). Conversely, the spectra of the 
dithionite-treated Mo-peptide starts to lose the intensity, in the Mo-thiolate charge-transfer region, 
when treated with more than 0.2 equivalents of dithionite (data not show). Ascorbate is a weaker 
reducing agent (282 mV vs. NHE 167) so is not able to reduce the Mo-scaffold neither coordinate 
with the Mo atom. 
Ultimately these results suggest that the Mo-centre can only be reduced by dithionite and not 
by DTT neither ascorbate. However, the DTT-treated Mo-α3DIV-L21C peptide suggests plausible 
coordination of the sulphur atom of this exogenous thiol ligand with the Mo-centre, like observed 
in the DTT-treated Mo-Rd derivative 52. Ultimately, the thiol-treated Mo-α3DIV-L21C peptide may 
be proposed as a model for some periplasmatic nitrate reductases 168,169. 
 
 
 
3.6. Electrochemical characterization: Cyclic Voltammetry (CV) 
The electrochemical behaviour of the apo- and Mo-peptide forms, in TCEP-induced reducing 
conditions, was studied, through cyclic voltammetry (CV), to gain information on their redox 
properties. Preliminary electrochemical studies, in a thin-layer regime (limited diffusion, attained 
by the physically immobilization of the biomolecule with a membrane on the electrode surface), 
suggested that the Mo-α3DIV-L21C scaffold exhibits a cathodic peak potential (Epc) of -423 mV 
vs. NHE and an anodic peak potential (Epa) of -389 mV vs. NHE. The voltammogram displays a 
quasi-reversible CV peak profile with a formal potential (E0’) of -406 mV vs. NHE (Fig. 3.29). This 
transition was assigned to the Mo(VI)/Mo(V) redox couple and, although slightly more positive,  it 
is in agreement with the reduction potential determined for the Mo-substituted rubredoxin (E0’ = -
493 mV vs. NHE) 52. Furthermore, some molybdoenzymes from the DMSOR family (Mo-bis PGD 
enzymes), such as the aldehyde oxidoreductase enzyme from D. gigas, also display a reduction 
potential of -415 mV and -539 mV vs. NHE for the Mo(VI)/Mo(V) and Mo(V)/Mo(IV) couples, 
respectively 170,171.  
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The redox pair peaks present a broad profile that may be the consequence of non-preferential 
protein orientation towards the electrode surface with the consequent low heterogeneous 
electronic constant rate (not calculated at this point) 172,173. The α3DIV-L21C scaffold presents a 
more negative superficial electrostatic charge, essentially in the metal-binding site region (Fig. 
3.30), which means that repulsion effects near the graphite electrode and the cellulose membrane 
(both also negative) may occur. This repulsive interaction may push away the negatively-charged 
Mo-Cys binding site in the opposite direction of the cellulose membrane, leading to a longer 
electronic pathway and consequently a low peak definition. The attempt to coat the electrode with 
a positive-charge electron transfer promoter (neomycin sulphate) was not successful in improving 
the voltammetric response and more assays should be performed in the future, such as using 
different electrode modifications.  
Furthermore, the signal intensities for both processes are distinct. The current intensity (Ipa) 
for the oxidation process (Epa = -389 mV vs. NHE) was 0.0115 µA and for the reduction process 
(Ipc) (observed at Epc = -423 mV vs. NHE) was 0.0221 µA. These results suggest that the 
molybdenum ion is initially in the +6 oxidation state within the α3DIV-L21C scaffold.  These results 
are further supported by a better peak definition in the reduction process, which indicates an 
easier metal reduction from the +6 to +5 oxidation state, than the opposite oxidation process. 
Further electrochemical studies are required to ensure an accurate determination of the E0’ for 
Figure 3.29. Normalised thin-layer cyclic voltammetry of the apo- and Mo-α3DIV-L21C pep-
tides (scan rate: 20 mV.s-1; WE: pyrolytic carbon; RE: saturated calomel electrode (potentials 
converted to NHE reference scale); CE: platinum electrode; membrane cellulose 3.5 kDa 
cut-off; Eoc = -0.2 V; anaerobic chamber: [O2]max = 3.5 ppm). 
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the Mo-α3DIV-L21C peptide, namely using different techniques such as differential pulse 
voltammetry (DPV) or square-wave voltammetry (SWV). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.30. Surface electrostatic potential of the Mo-α3DIV-L21C peptide. Negative potentials at 
red, neutral at white and positive at blue. The electrostatic potentials were calculated according to 
Coulomb's law and with Poisson-Boltzmann (PB) electrostatics calculations from Chimera 1.11. 
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4. Chapter 4. Conclusions 
Over the past 30 years, the field of artificial enzymes is developing promptly. Accommodated 
in this area, a de novo protein design is a novel approach that exploits the construction of specific 
metal-binding sites using small-scaled, simple and stable synthetic peptide scaffolds, to mimic 
specific catalytic functions of complex metalloproteins and, ultimately, shed light on the dilemma 
of protein structure-function relationship.  
The data reported confirmed the incorporation of a molybdenum atom within the rubredoxin-
type centre of a de novo designed apo-α3DIV-L21C three-helix bundle peptide. The metal 
incorporation in the tetracysteinyl active-site was assessed by the emerging of two broad 
absorption bands at 320 nm (ε320nm = 7400 M-1.cm-1) and at 470 nm (ε470nm = 2000 M-1.cm-1) 
upon the reconstitution procedure, which are specific of thiolate-Mo charge-transfer bands. The 
1:1 peptide:metal ratio was estimated by metal and protein quantification. Moreover, CD studies 
in the visible region further corroborate the strong interaction between the peptide and the metal, 
by the appearance of a broad positive absorption band, with a maximum at 392 nm, that is absent 
in both CD spectra of the apo-peptide and TTM compound. 
Furthermore, CD studies, in the far-UV region, under TCEP-induced reducing conditions, 
indicate a similar melting temperature for both apo- and Mo-α3DIV-L21C peptides, at 60.0 ºC and 
60.3 ºC respectively, and an equal α-helical structure conformation, suggesting that the Mo 
incorporation in the active-site do not have major repercussions in the secondary structure 
content. An enthalpy of folding (ΔH) of -100.6 kJ.mol-1, for the apo-form, and of -80.9 kJ.mol-1, for 
the Mo-form, attested the spontaneous folding process due to hydrophobic interactions, however, 
may suggest a slight destabilization imposed by the metal in the folding process.  
Additionally, CD studies in the near-UV region reveal some deviations in the tertiary structure 
fingerprint for both apo- and Mo-peptides, with and without reducing agent, indicating small 
changes in the side-chain environment of the aromatic residues. The estimation of 
4 
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thermodynamic parameters for the Mo-α3DIV-L21C peptide, in the CD visible region, implying 
that the loss of the molybdenum atom in active-site occurs at higher temperatures (Tm = 73.6 ºC) 
and that the coordination of Mo within the metal-binding site is driven by a spontaneous process 
(ΔH = -125.9 kJ.mol-1). 
CD studies, under non-reducing conditions, reinforce the role of a reducing agent in promoting 
a slight destabilization of the tetracysteinyl environment. In the far-UV region, no stabilization 
plateau was achieved, and in the visible region, no regain in the visible signal upon temperature 
cooling was observed. These observations demonstrate that a reducing environment near the 
tetracysteinyl region prevents disulphide bridges formation and leads to a unique structural 
conformation that is slightly less stable. Without a reducing agent, the cysteine residues can 
covalently bind in a variety of arrangements, leading to several structural conformations, in the 
metal-binging site, that preserves the α-helical secondary structure and, ultimately, impose a 
more thermally-stable scaffold. 
The thermal-stability of both apo- and Mo-forms were also evaluated by DSC analysis, under 
TCEP-induced reducing conditions. The data for the Mo-α3DIV-L21C peptide fitted well to a 
reversible monomeric (one-peak) two-state model with a Tm of 66.1 ºC and a ΔHvan’t Hoff/ΔHcal 
ratio of 1.09. The midpoint of the unfold transition in slightly different from the ones estimated 
from the CD analysis, but a ΔHvH/ΔHcal ratio near 1 (one) suggest that the model fitted correctly 
the experimental data. The thermodynamic parameters for the apo-α3DIV-L21C peptide were not 
estimated at this point, since the data shows a multiplicity of signals, from diverse structural 
conformations, even in slightly TCEP-induced reducing conditions. 
Preliminary electrochemical analysis (using cyclic voltammetry in a thin-layer regime), suggest 
that the metal initial oxidation state is Mo(VI) within the tetracysteinyl active-site with a formal 
potential (E0’) of -406 mV vs. NHE. The results suggest that the redox-active Mo-centre can 
undergo a one-electron transfer process (Mo(VI)/Mo(V)). Furthermore, incubations of the Mo-
α3DIV-L21C peptide with several reducing agents (ascorbate, DTT and dithionite) are in 
agreement with this hypothesis. Interestingly, an increment of the UV-vis spectral profile, in the 
thiolate-Mo charge-transfer region, upon incubation with DTT and dithionite may suggest 
additional coordination of the molybdenum atom with an exogenous thiol ligand, as observed in 
the Mo-substituted derivative from rubredoxin. 52  
Taking into consideration the assemble of results obtained, the reconstitution of the α3DIV-
L21C peptide with Mo can be considered an interesting structural model for the Mo-bis PDG 
enzymes, or DMSOR family, due to the nature of the ligands present in the first coordination 
sphere of Mo. At this moment, we speculate that the Mo-substituted scaffold harbours a 
Mo=O(OH)(–SCys)4 centre since it displays spectroscopic properties similar to the ones in the 
active-site of the Mo-bis PDG enzymes. 
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4.1. Future Perspectives  
In the future, further spectroscopic characterization and activity studies are envisaged in order 
to ensure that the novel Mo-α3DIV-L21C peptide is a structural and functional analogue of some 
Mo-bis PGD enzymes. These spectroscopic studies will include electron paramagnetic resonance 
(EPR) spectroscopy and resonance Raman (RR) spectroscopy, that are essential to confirm the 
molybdenum oxidation state (in native and transient states) and define the redox process, within 
the tetracysteinyl environment, and to establish the first coordination sphere in the reconstituted 
Mo-peptide and in the thiol-treated Mo-peptide.  
EPR is a suitable technique to follow the reduction of the oxidised Mo-α3DIV-L21C scaffold 
with DTT and/or dithionite of the initial oxidation Mo(VI) state  (EPR silent species) and the 
emergence of signals characteristics of the EPR active species Mo(V). Additionally, increasing 
the reduction time may attest if the Mo-tetracysteinyl centre can undergo a two-electron transfer 
reaction by the decreasing of the signal since the Mo(IV) species is EPR silent. 174 
Resonance Raman studies will add information on the first coordination sphere composition, 
assessed by the appearance of broad cysteinyl S-Mo(VI) charge transfer bands (at ~400 nm) and 
Mo-S stretching and bending vibrational modes (between ~300 – 400 cm-1) 175. Furthermore, the 
expansion of Mo coordination sphere with oxygen atoms and/or hydroxyl groups may also be 
evaluated by RR spectroscopy by the appearance of broad bands above 850 cm-1 typical of 
Mo=O symmetric stretching modes 176. Ultimately, this expansion of Mo coordination number can 
be assessed and complemented by nuclear magnetic resonance (NMR) spectroscopy studies, 
using an active nuclei compound, such as the 19F-active 2,2,2-tri-fluoroethanethiol (TFET), to 
confirm the binding of an exogenous thiol ligand in the active-site, resulting in a Mo=O(SR)(–
SCys)4 centre 177. 
Magnetic circular dichroism (MCD) spectroscopy and additional electrochemical assays will 
complement the EPR studies. In addition, studies of the pH dependence behaviour of the Mo-
α3DIV-L21C scaffold and the binding affinity between the molybdenum and the peptide must be 
attained if possible.  
Concluded the structural characterization studies, the capability of the metal active-site to 
undergo in a catalytic function must be inspected. The activity studies performed will depend on 
the metal first coordination sphere. For instances, with a Mo=O(OH)(–SCys)4 moiety we can test 
the oxidation of arsenite to arsenate and/or the reduction dimethyl sulfoxide to dimethyl sulphide, 
to produce a model for the enzymes arsenite oxidase (A. faecalis) and dimethylsulfoxide 
reductase (R. sphaeroides), respectively. Diversely, the Mo=O(SR)(–SCys)4 centre can be a 
model for the periplasmatic nitrate reductase (E. coli) or the polysulfide reductase (T. 
thermophilus) enzymes, by testing the reduction of nitrate to nitrite or the inorganic sulphur 
reduction to sulphide, respectively. Moreover, the possibility of developing a Mo=(SR)2(–SCys)4 
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moiety can further expand the models, such as for the oxidation of formate to carbon dioxide 
performed by the formate dehydrogenase (R. capsulatus). 
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